Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,14494,98,0.64 [0.21-1.98],0.442231658480113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,14109,95,1.15 [0.79-1.66],0.4729087195987524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,16497,109,1.04 [0.77-1.41],0.7831605382169702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,14003,91,1.92 [1.22-3.02],0.0050224756937164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,16374,104,1.04 [0.77-1.42],0.7878309687844647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,16497,109,1.07 [0.83-1.38],0.6040262094630172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,14485,98,1.02 [0.89-1.16],0.7660340501150514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,14003,91,0.87 [0.64-1.20],0.3973196312440199
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16222,104,1.49 [1.24-1.78],2.2136848648179063e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",14209,95,1.01 [0.77-1.33],0.9252026138399904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",14466,98,1.03 [0.83-1.27],0.8193727841805573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,16388,111,1.23 [0.67-2.27],0.5078721826293358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,14485,98,1.05 [0.52-2.09],0.895624773872944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,16271,105,1.92 [1.51-2.45],1.2951860121485458e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,14181,95,1.42 [0.81-2.48],0.2240778218922966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,14404,96,1.11 [0.93-1.32],0.2370339124381396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16562,112,1.21 [0.89-1.62],0.2196928802136188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,14046,96,0.95 [0.62-1.47],0.8274976997748146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,16674,110,1.83 [1.21-2.78],0.0045206650908162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,16693,107,1.26 [0.96-1.65],0.097128320589237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,14417,95,1.03 [0.63-1.67],0.9156605525398388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,14046,96,0.84 [0.66-1.08],0.1769359588270261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,14003,91,0.87 [0.48-1.59],0.6487931965067399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",16271,105,1.13 [0.77-1.65],0.5287428657895037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,14003,91,0.98 [0.69-1.39],0.9013835321660216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,16279,105,1.05 [0.62-1.77],0.8619473980933894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,16395,104,1.80 [0.96-3.37],0.0657320099987896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,16562,112,1.65 [1.29-2.10],6.235791289675969e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,14003,91,1.31 [0.93-1.85],0.1186525565788811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,14129,95,1.10 [0.81-1.48],0.5509447120140625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,16739,109,1.46 [0.95-2.25],0.0853507709952416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,16509,108,2.31 [1.65-3.23],1.131401487585115e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14046,96,1.81 [1.09-3.02],0.0230126782230833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16271,105,1.45 [0.83-2.53],0.1877054628178154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16424,105,1.19 [0.74-1.92],0.4809684361467298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16739,109,1.13 [0.69-1.85],0.6198706638293701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16664,107,2.36 [1.39-4.00],0.0014757949440736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14404,96,2.76 [1.63-4.69],0.0001689370044218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,14046,96,0.87 [0.45-1.68],0.6784804030291713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16779,112,2.16 [1.06-4.42],0.0344875266861391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16497,109,1.37 [0.91-2.08],0.1357818975031876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,16271,105,0.99 [0.58-1.68],0.9712742581814328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,14046,96,1.07 [0.61-1.88],0.8142184870194363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16637,112,0.67 [0.46-0.97],0.0326365178865475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,14479,98,3.97 [2.62-6.01],7.339398311372729e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,14109,95,0.79 [0.34-1.83],0.5838849700683352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,14466,98,1.05 [0.65-1.72],0.832813071185957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,16222,104,1.07 [0.70-1.64],0.759999310819373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,14181,95,1.07 [0.81-1.41],0.6206877950963651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,16395,104,2.30 [1.41-3.73],0.0008011357216215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,14181,95,1.25 [0.76-2.05],0.390033486260115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,14404,96,1.93 [1.42-2.62],3.030771457626869e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,16643,113,2.58 [1.50-4.45],0.0006315824582031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,16718,111,2.53 [1.78-3.59],1.879487984699829e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,14466,98,1.47 [0.73-2.97],0.2841890149821378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,16497,109,1.65 [1.42-1.91],3.648139978224184e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,16562,112,0.95 [0.51-1.76],0.8618607587188407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,14023,89,0.91 [0.66-1.25],0.5584728264658027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,14181,95,1.16 [0.90-1.48],0.2500081128078021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,16271,105,1.14 [0.93-1.40],0.2168805624541076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,14494,98,0.80 [0.61-1.06],0.1224873279507406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,16723,107,1.62 [0.82-3.21],0.1653217883419765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,14003,91,1.02 [0.77-1.36],0.8744561485736173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,14181,95,0.95 [0.74-1.21],0.6748476337026743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,14494,98,1.04 [0.40-2.71],0.9355887189897788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,16371,104,1.20 [0.92-1.56],0.1785288427484136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,14023,89,0.84 [0.69-1.02],0.083654275500671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,16537,113,1.22 [0.81-1.82],0.3349826079245357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,16055,101,1.09 [0.91-1.30],0.3603407274104522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,16186,103,1.04 [0.78-1.40],0.7835798948088227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,16643,113,2.33 [1.54-3.53],5.897272793556917e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,16739,109,1.23 [0.88-1.72],0.2339235698922003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,14485,98,1.03 [0.43-2.42],0.9539718210719328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,16562,112,1.57 [1.30-1.90],3.8057783473031615e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,16562,112,1.16 [0.91-1.48],0.2445369184134143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,14109,95,1.05 [0.56-1.99],0.876050792264781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,14109,95,0.93 [0.47-1.82],0.8295949552163691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,14417,95,0.97 [0.72-1.32],0.8670997394944355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,14485,98,1.04 [0.51-2.10],0.9197016450895104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,16553,110,1.22 [1.00-1.50],0.0483477065341004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",14096,95,1.00 [0.79-1.26],0.972705882666415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,16222,104,0.94 [0.67-1.32],0.7114054044355156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,14109,95,1.04 [0.73-1.47],0.835628268758865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",16473,109,1.17 [1.00-1.37],0.0491266453839314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,16562,112,1.15 [0.89-1.48],0.295187087322346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",14454,97,1.17 [0.97-1.41],0.0953846569503693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,14181,95,0.50 [0.24-1.04],0.062559083173992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,16222,104,1.11 [0.88-1.40],0.3861419339444771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,14096,95,1.59 [1.28-1.97],2.511444143200292e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,16271,105,1.05 [0.76-1.46],0.7529735111447908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,14046,96,1.47 [1.19-1.83],0.000421630762879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,16186,102,0.98 [0.75-1.27],0.8591688800290016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,14444,95,0.98 [0.84-1.15],0.8308993464163389
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,16154,103,0.92 [0.68-1.27],0.6255714960829155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,16779,112,8.45 [4.01-17.80],1.9743597655303624e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,16588,110,1.66 [1.28-2.15],0.0001142718216017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",14417,95,1.33 [1.02-1.73],0.0320398135874623
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16501,110,1.10 [0.89-1.36],0.3745922077482538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",14444,95,1.69 [1.20-2.38],0.002783288878911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,14209,95,1.06 [0.69-1.62],0.8061260716608651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,14046,96,1.02 [0.87-1.19],0.8401404165836461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",16497,109,1.09 [0.93-1.29],0.2814621438742578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,16279,105,0.56 [0.33-0.93],0.0262068957650317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,16695,107,1.47 [0.64-3.36],0.3662013217612362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,14479,98,0.86 [0.41-1.82],0.6898789543171828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,16186,102,1.02 [0.77-1.35],0.879228342245229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,14096,95,0.99 [0.66-1.48],0.9555282339236114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,16497,109,1.79 [0.87-3.68],0.1110414198854059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,16279,105,0.62 [0.42-0.90],0.0129900353546063
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,14181,95,2.06 [1.31-3.22],0.0016246167869175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,14359,94,1.20 [0.83-1.73],0.3424657956443226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,14454,97,0.90 [0.68-1.18],0.4334356769186265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13533,96,0.90 [0.60-1.33],0.5912597543152642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,15916,107,1.14 [0.81-1.62],0.4512861751544911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,15445,104,1.09 [0.77-1.54],0.6350858962767298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,16565,108,0.54 [0.32-0.92],0.0231350030744732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,16502,113,0.96 [0.79-1.17],0.7046414949121057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,16723,107,1.94 [1.28-2.93],0.0017627653900964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,16339,111,1.92 [1.09-3.39],0.0238225806712048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,16589,113,1.74 [1.16-2.62],0.0070282493157038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,16604,109,0.72 [0.45-1.16],0.1747868323701314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,16618,113,1.79 [1.23-2.60],0.0022689801668138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,16723,107,1.57 [0.99-2.48],0.0549095136680168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,14003,91,0.92 [0.68-1.24],0.5720554882282565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,14046,96,1.16 [0.91-1.48],0.2230071859468526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,13971,93,0.82 [0.56-1.20],0.3046281631157015
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,16222,104,1.02 [0.76-1.38],0.8775391352573014
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,14109,95,0.68 [0.37-1.26],0.2198500791480096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,16645,111,2.13 [1.26-3.62],0.0050114174963147
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,14105,94,1.47 [1.03-2.08],0.0326882063981109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,16186,102,1.10 [0.91-1.35],0.3286625086199669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,16512,110,1.00 [0.77-1.29],0.9821684070242068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,13889,93,1.07 [0.81-1.41],0.6268797239993926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,16664,107,0.98 [0.77-1.26],0.9029996169072682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,16491,112,1.16 [0.93-1.46],0.1934778809439366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,16135,101,1.09 [0.60-1.96],0.7774553176505984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],16279,105,0.86 [0.61-1.21],0.3847790467333757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,16666,111,1.51 [0.86-2.63],0.1483886903547259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,14417,95,1.09 [0.86-1.39],0.480120559873039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,14096,95,0.97 [0.64-1.47],0.8752629042333759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,14404,96,1.08 [0.84-1.40],0.5319753366469491
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,14454,97,1.15 [0.77-1.71],0.4894766477144191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16497,109,1.08 [0.74-1.57],0.7037191298074922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,14346,98,0.57 [0.33-0.97],0.0391570992088171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16664,107,1.10 [0.83-1.46],0.5266525781268029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,16562,112,0.98 [0.71-1.36],0.9040540776330768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,14494,98,0.47 [0.21-1.04],0.063717268460399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,14485,98,1.61 [1.12-2.32],0.0099065163939678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,14494,98,1.05 [0.60-1.83],0.8675601612664898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,14485,98,0.78 [0.35-1.76],0.5492391993394563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,14109,95,0.84 [0.54-1.33],0.4601309727207401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,14467,98,0.58 [0.33-1.01],0.0525894400881457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,13868,94,0.47 [0.25-0.87],0.0163938768339434
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,14494,98,1.10 [0.85-1.42],0.4651152894014905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,14485,98,0.49 [0.37-0.65],8.437572213874132e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,16588,110,1.27 [0.82-1.97],0.2800410822816005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,14485,98,0.77 [0.53-1.14],0.1907831393785754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,16634,109,0.31 [0.18-0.53],3.082591377612891e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,16572,110,0.97 [0.75-1.25],0.8087219502527093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,14181,95,1.05 [0.87-1.25],0.6237236789107488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,16391,105,0.96 [0.66-1.38],0.8178254897961097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,14209,95,1.03 [0.78-1.36],0.8373690057337531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,16497,109,1.92 [1.37-2.69],0.0001387272338639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,14404,96,1.06 [0.88-1.27],0.5334133459166355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,14444,95,1.01 [0.75-1.34],0.969270842565797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,16486,105,1.19 [0.85-1.65],0.3097789710001756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",14417,95,0.95 [0.59-1.52],0.837606064211265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,16222,104,1.12 [0.76-1.65],0.5603022131021074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,16222,104,0.98 [0.73-1.32],0.8803359126552197
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,14209,95,1.39 [0.94-2.04],0.0999393889982802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,14181,95,1.08 [0.85-1.37],0.5442458350520148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,13971,93,1.06 [0.83-1.34],0.6443295300396634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,14454,97,1.14 [0.91-1.41],0.2499504474989519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,14444,95,1.01 [0.82-1.24],0.9429634188837532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,16536,110,0.99 [0.84-1.16],0.8888312086349883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,14023,89,1.23 [0.96-1.56],0.0975498291679053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,14023,89,1.00 [0.60-1.67],0.9903572789210058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,16186,102,1.25 [0.90-1.74],0.1799801417177385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,14003,91,1.04 [0.78-1.38],0.7860885805200386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,14003,91,1.13 [0.69-1.86],0.6344053817721768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,14023,89,0.86 [0.58-1.26],0.4283087615925751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,16279,105,1.04 [0.64-1.68],0.8857581066809093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,14003,91,0.76 [0.48-1.22],0.2551548752603589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,16588,110,1.55 [1.10-2.19],0.0114116260541691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,16497,109,1.14 [0.84-1.54],0.4166946148896082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,16666,111,1.21 [0.75-1.93],0.4345864629204129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,14023,89,1.04 [0.76-1.41],0.8242690416658713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,16279,105,0.92 [0.61-1.41],0.7095073272315253
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,14332,98,1.21 [0.82-1.79],0.3312667806341487
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,16424,105,1.25 [0.87-1.77],0.2234166245250781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,16424,105,1.95 [1.15-3.29],0.0128877328606092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,14485,98,1.94 [0.98-3.81],0.0556413859402018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,14466,98,1.49 [0.89-2.48],0.1287035414231066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,14444,95,1.13 [0.84-1.52],0.4147514898597745
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,14109,95,0.99 [0.82-1.21],0.9542995551982252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,14003,91,1.07 [0.82-1.38],0.6213458807876833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,16186,102,0.85 [0.61-1.18],0.3249154884117767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,13971,93,0.88 [0.48-1.62],0.6869504029890909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,14404,96,1.03 [0.82-1.30],0.793809748776124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,16222,104,1.11 [0.83-1.48],0.4740047278218389
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,16637,112,1.17 [0.91-1.49],0.2170823975931065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,14003,91,1.47 [1.12-1.91],0.0046807865578295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,14003,91,0.87 [0.46-1.66],0.6777574939030986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,14003,91,0.93 [0.55-1.60],0.8028657359861221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,13971,93,0.90 [0.55-1.47],0.6770568226320571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,14003,91,1.10 [0.81-1.48],0.5542385006994882
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",14003,91,1.24 [0.94-1.64],0.1320722635525654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",16643,113,1.05 [0.90-1.22],0.5386869882068772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",16186,102,0.79 [0.50-1.24],0.3088213312906002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,16222,104,0.99 [0.63-1.54],0.9573590916444418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,16497,109,0.79 [0.40-1.57],0.4995026566639511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,16156,101,1.04 [0.80-1.36],0.7707925360717041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,14109,95,1.08 [0.82-1.42],0.5718204027581292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,14003,91,0.98 [0.80-1.22],0.8847435598692175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,14404,96,1.83 [1.24-2.70],0.0022663690259072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",14494,98,1.11 [0.35-3.54],0.8647874504929569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,16186,102,0.94 [0.74-1.20],0.6166556379765384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,14023,89,0.95 [0.78-1.16],0.6052231323838693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,14444,95,1.22 [0.83-1.78],0.3052991964230085
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,14454,97,1.04 [0.76-1.41],0.8258238392582388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,16536,110,0.95 [0.79-1.14],0.5764260785026951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,16666,111,1.67 [0.93-3.00],0.0875969466456159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,14444,95,1.18 [0.84-1.68],0.3374410468958893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,16060,105,1.21 [1.00-1.48],0.0536619495412835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,14494,98,1.49 [1.03-2.15],0.0322851726977261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,14003,91,0.41 [0.14-1.18],0.0966847035390241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",14109,95,1.52 [0.88-2.61],0.132268791830113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",16643,113,2.03 [1.14-3.62],0.0162220104365756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",16588,110,1.42 [0.70-2.85],0.3291460688960728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,14046,96,1.01 [0.51-1.99],0.9721620623183584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,16536,110,0.98 [0.77-1.24],0.8702167296507686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,16395,104,0.93 [0.61-1.43],0.7387483425678365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,14046,96,1.30 [0.90-1.89],0.1573052686130998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,16271,105,0.93 [0.57-1.52],0.7819904193805606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16222,104,1.68 [1.36-2.07],1.2842901963580115e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,16222,104,1.33 [0.74-2.40],0.3396686135113859
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,16536,110,0.99 [0.84-1.16],0.8823246690446467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,14454,97,1.25 [0.99-1.58],0.0644819779102881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,14096,95,1.13 [0.93-1.37],0.2285777109234578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,16163,102,1.11 [0.91-1.35],0.3004733748546789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,16588,110,3.95 [2.35-6.65],2.2481065824928165e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,16424,105,0.66 [0.40-1.07],0.0925905607562621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",14466,98,1.67 [0.95-2.92],0.0732101719764604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",14023,89,0.59 [0.36-0.98],0.0416261518841807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,14215,97,0.54 [0.36-0.83],0.0049791006393846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,14404,96,1.12 [0.81-1.55],0.4953400060327025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,14454,97,1.07 [0.88-1.31],0.476688535474717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16536,110,1.15 [0.76-1.74],0.5220663507288993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,14046,96,1.11 [0.81-1.53],0.5041428726759363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,13971,93,1.27 [1.00-1.62],0.0546244999160185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,14417,95,1.32 [0.94-1.84],0.1090589203933019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,16536,110,1.03 [0.85-1.24],0.7755423774904572
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,14479,98,1.02 [0.81-1.29],0.8578239345752143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,14109,95,1.14 [0.83-1.59],0.4188353987126717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,13971,93,1.24 [0.88-1.75],0.2206380712098738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,14479,98,1.04 [0.83-1.30],0.7250435874485266
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,16190,104,1.05 [0.90-1.21],0.5416146048199585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,14023,89,0.87 [0.64-1.18],0.3673846763487601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,14003,91,0.48 [0.22-1.03],0.0589118061031183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,16536,110,0.97 [0.75-1.25],0.8086884447758882
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,16588,110,0.97 [0.80-1.17],0.7412749189841161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,16222,104,0.94 [0.71-1.24],0.6428703150909347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,16779,112,1.37 [0.81-2.30],0.2378915305560508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,14046,96,1.24 [0.78-1.97],0.3681360199958949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,14023,89,1.00 [0.76-1.32],0.9924093846131732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,14454,97,1.05 [0.64-1.71],0.8493041924838297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,16588,110,1.12 [0.88-1.43],0.3492235916489258
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,14181,95,1.28 [0.64-2.53],0.4857930540279161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,16395,104,1.36 [0.96-1.92],0.084585992896619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,16252,105,1.13 [0.74-1.73],0.5772957531058112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,14181,95,3.24 [1.78-5.90],0.0001179501847066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14466,98,1.10 [0.62-1.94],0.7520167738688311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14046,96,1.17 [0.75-1.83],0.4814842825846479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,16271,105,0.89 [0.42-1.89],0.7629205253375413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,14023,89,1.19 [0.85-1.68],0.3146171134722562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,14109,95,1.04 [0.72-1.50],0.8331596270589976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,13622,95,0.92 [0.77-1.11],0.3800851672553419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,16535,110,0.94 [0.72-1.23],0.6643045654030539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,14437,98,1.01 [0.77-1.33],0.9400147778907224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,14270,96,1.02 [0.85-1.23],0.8076361627343092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,14209,95,1.36 [0.77-2.40],0.2938081472786322
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,14023,89,0.97 [0.54-1.74],0.9111576938713292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,14003,91,0.86 [0.54-1.37],0.5176430882579308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,14003,91,1.16 [0.68-1.98],0.582958183087414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,16186,102,0.78 [0.52-1.17],0.2345039767469914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,14023,89,0.69 [0.38-1.25],0.2204870953495706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,14444,95,1.20 [0.73-1.96],0.4798323642930986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,16714,109,1.95 [0.86-4.38],0.1081399442623436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,13971,93,1.07 [0.61-1.88],0.8010012444383923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16696,107,0.91 [0.65-1.27],0.5793059026903329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,16696,107,1.85 [1.48-2.31],5.471130380984133e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,16222,104,0.83 [0.64-1.07],0.1482116655016317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,14494,98,1.02 [0.40-2.63],0.9613892825753494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,13971,93,1.24 [1.08-1.44],0.0028789812506316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,14386,94,0.73 [0.40-1.33],0.3064615239871402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,16643,113,2.24 [1.28-3.93],0.0047430754970486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,16536,110,1.67 [1.15-2.42],0.0066256647797369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,13971,93,1.14 [0.74-1.74],0.552217495703476
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,16186,102,1.41 [1.16-1.71],0.000489184977265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,14003,91,1.27 [0.74-2.18],0.388633683189458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,16661,109,1.47 [0.69-3.12],0.3181249946292329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",14444,95,0.91 [0.67-1.24],0.5513569603018367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,14046,96,0.82 [0.51-1.31],0.4035068600086382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16666,111,1.97 [1.45-2.68],1.536292764627974e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14181,95,1.39 [0.80-2.40],0.2429868317530208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,14444,95,1.87 [1.27-2.75],0.0015095823903304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,14153,94,1.20 [0.78-1.84],0.4125792059924735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,14494,98,0.51 [0.22-1.20],0.1247116243126624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,14463,98,0.47 [0.23-0.94],0.0320392610882042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,14494,98,0.47 [0.19-1.12],0.089005652682446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,16634,109,1.11 [0.51-2.43],0.7980597279657815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,16156,101,1.02 [0.68-1.53],0.9303109793308664
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,14096,95,1.05 [0.76-1.45],0.7582481109243326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,13736,94,1.37 [0.94-1.99],0.1007309266423676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,16637,112,0.85 [0.55-1.30],0.4429737215833788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,14494,98,0.32 [0.08-1.26],0.1035828167936245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,14125,97,3.96 [2.26-6.93],1.4466199463745618e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,14454,97,1.66 [0.93-2.96],0.0879147609715967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,14494,98,0.70 [0.37-1.32],0.2701549501066929
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,14485,98,0.88 [0.63-1.24],0.4609844541356428
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,14404,96,1.03 [0.81-1.30],0.833117524119585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,16248,105,1.15 [0.87-1.53],0.3307285365961103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,16222,104,1.52 [1.05-2.20],0.0256125940641574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,16497,109,1.62 [0.99-2.66],0.0553977228074151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,16392,109,1.05 [0.89-1.24],0.5484871118057993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,16723,107,0.94 [0.58-1.53],0.8122500094085823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,16525,110,1.17 [0.92-1.47],0.1942688068684757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,16756,111,1.15 [0.87-1.51],0.3266547922202439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,16779,112,0.47 [0.24-0.94],0.0317118327982186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",16271,105,1.36 [1.15-1.60],0.0003584211137893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,16535,110,0.65 [0.50-0.85],0.0016853594743159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,14209,95,1.22 [0.74-2.01],0.4470517329268499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,14046,96,0.39 [0.14-1.09],0.0723375035768604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,16723,107,1.79 [1.32-2.43],0.0001634805557134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,14096,95,1.18 [0.89-1.56],0.241246563135981
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,14023,89,0.76 [0.38-1.50],0.4268454407121442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,14003,91,1.01 [0.72-1.42],0.944940891822624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,14023,89,1.07 [0.78-1.48],0.6788273745549189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,14444,95,1.06 [0.84-1.34],0.6197588175052516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,14157,95,1.09 [0.90-1.33],0.3895288217780349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,14096,95,0.66 [0.36-1.18],0.1612753349528736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,16497,109,1.09 [0.74-1.60],0.6680739535743032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,16186,102,0.87 [0.47-1.60],0.6538394953736593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,16394,104,1.15 [0.89-1.49],0.279358962827514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,14454,97,1.15 [0.74-1.80],0.5356744170901779
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16666,107,0.97 [0.82-1.14],0.6903283396331739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,14109,95,1.07 [0.83-1.40],0.5910787207878814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,14003,91,0.50 [0.26-0.97],0.0406300059530383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16222,104,1.09 [0.73-1.63],0.6710507379723513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14096,95,1.00 [0.69-1.45],0.9886710249162368
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,14444,95,1.01 [0.84-1.21],0.9435073497297516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,16502,112,3.28 [1.47-7.32],0.0037695167918612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,16453,105,1.10 [0.82-1.48],0.5090325622485851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,14417,95,0.77 [0.42-1.40],0.3891763048379132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,14454,97,1.03 [0.87-1.23],0.7296479242041103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,16186,102,0.98 [0.70-1.38],0.9180847165966286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,14096,95,1.14 [0.71-1.82],0.5899925939609312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,16186,102,1.20 [0.96-1.50],0.1098443222280775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,16186,102,1.05 [0.82-1.34],0.7124706278984272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,16536,110,0.97 [0.75-1.25],0.7970706148472265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,16779,112,1.07 [0.88-1.29],0.5127237994034548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,14209,95,1.11 [1.00-1.22],0.0531325896011179
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,14454,97,1.02 [0.81-1.29],0.8667659122029427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,16665,107,1.10 [0.84-1.44],0.4724222838272651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,14046,96,0.87 [0.63-1.22],0.4256535912293667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,14003,91,0.91 [0.57-1.43],0.6761000104486208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,14275,97,1.04 [0.73-1.48],0.8344210793168246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,16534,110,1.21 [0.97-1.49],0.084301887993275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,14023,89,1.18 [1.00-1.39],0.0473121718503684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,16723,107,1.53 [0.97-2.41],0.0692326321009471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,14109,95,1.75 [1.32-2.31],9.143317389497564e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,14003,91,0.41 [0.19-0.90],0.0271495813638573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,16424,105,1.02 [0.80-1.29],0.8879054069295648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,14454,97,1.12 [0.82-1.53],0.4662094659025714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,14417,95,1.04 [0.70-1.55],0.8400884399253069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,14096,95,0.85 [0.44-1.68],0.6466120971681544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,14444,95,1.17 [0.93-1.45],0.1741446027183515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,16562,112,1.40 [0.90-2.16],0.1342512541836818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,14109,95,0.83 [0.60-1.15],0.2693241229756724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,16739,109,1.34 [0.84-2.12],0.2184806656113108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,16712,109,0.97 [0.76-1.24],0.7928845580174475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,16565,108,0.97 [0.63-1.49],0.895973902798088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,16779,112,1.76 [1.25-2.47],0.0011572824249686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,16779,112,1.12 [0.81-1.56],0.4911710047327351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,16553,112,0.98 [0.82-1.18],0.8618043241689645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,16365,108,1.11 [0.88-1.40],0.3759827120318597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,16696,107,0.95 [0.83-1.10],0.507039946254245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,16395,104,1.17 [0.85-1.62],0.3352549465749761
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,16739,109,1.23 [1.05-1.43],0.0084839162238217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,16643,113,1.48 [1.10-1.99],0.0092785057092613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,16427,111,1.07 [0.78-1.47],0.6723128838712478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,16643,113,0.91 [0.61-1.36],0.6511367177906384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,16618,113,1.03 [0.84-1.25],0.7962661715767168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,16739,109,1.32 [0.93-1.88],0.1174276289862129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,16536,110,0.89 [0.73-1.08],0.2434361767516361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,16562,112,0.92 [0.69-1.21],0.5435418739643146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,16471,110,1.01 [0.75-1.35],0.9567846020704692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,16536,110,1.28 [1.04-1.59],0.0223274181227605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,16604,112,1.22 [1.01-1.48],0.0373818279832883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,16666,111,1.04 [0.88-1.23],0.6187001247067719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,16536,110,1.12 [0.85-1.48],0.4173118619222942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,16695,107,0.95 [0.72-1.26],0.7255353227870305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,16465,109,1.04 [0.82-1.32],0.7445201596603501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,16559,113,1.00 [0.74-1.35],0.9944598981890912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,16750,112,1.75 [1.12-2.73],0.0138168832240149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,16723,107,1.18 [0.78-1.81],0.4321726878408944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,16588,110,1.07 [0.69-1.66],0.7576713653301071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,14209,95,0.81 [0.48-1.37],0.4364067317746789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,14046,96,0.80 [0.57-1.11],0.1751772260054178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,16424,105,1.04 [0.73-1.50],0.8199507003909111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,16222,104,0.87 [0.58-1.32],0.5244602853180877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,14404,96,1.22 [0.78-1.91],0.3842482100396429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,16588,110,1.64 [0.99-2.73],0.0548337140680091
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,16284,107,1.67 [1.16-2.40],0.0053941922877387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,16739,109,1.13 [0.80-1.61],0.4850421920085731
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,16666,111,2.17 [1.53-3.08],1.5635620768138823e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,16588,110,1.30 [0.81-2.11],0.2794870359524353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,14096,95,1.01 [0.59-1.71],0.984686501422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,16562,110,1.04 [0.91-1.19],0.545491056474723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,16637,112,0.88 [0.45-1.75],0.7255910801291794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,14003,91,0.99 [0.59-1.66],0.9712313471877816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,16536,110,1.22 [0.65-2.29],0.5378777551090497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,16483,110,1.21 [0.75-1.94],0.429213902731661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,16179,107,1.59 [1.03-2.45],0.0367486410936574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,16629,109,0.88 [0.57-1.38],0.5851675359394144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,16739,109,1.51 [1.03-2.21],0.0341043180520129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,14046,96,0.99 [0.61-1.58],0.9572945031483756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,16739,109,2.05 [1.13-3.70],0.0174308606891522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,14479,98,0.85 [0.53-1.38],0.5185244223009025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,16637,112,1.58 [1.09-2.31],0.016692041108181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,16424,105,1.68 [1.07-2.63],0.0238498266675174
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,16564,113,1.52 [0.96-2.42],0.0771423909688692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,16222,104,1.68 [1.22-2.33],0.0016176855297981
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,16562,112,0.98 [0.75-1.27],0.8635857577622374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,14181,95,1.28 [0.68-2.42],0.4457965102809434
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,16696,107,1.86 [1.18-2.92],0.0073871854651654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,16665,107,1.13 [0.75-1.70],0.571154921949891
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,16723,107,1.42 [1.04-1.94],0.0283862780431905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,16588,110,1.00 [0.64-1.55],0.9850233539385514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,16497,109,2.64 [1.68-4.14],2.58513734804804e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,16637,112,1.26 [1.01-1.58],0.039826075654622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,16647,105,0.89 [0.44-1.82],0.7546340099490767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,14046,96,1.02 [0.66-1.58],0.937166506010376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16497,109,1.43 [0.86-2.38],0.1698996242239589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,14023,89,1.07 [0.58-1.96],0.838388830819784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,14209,95,0.79 [0.43-1.47],0.4641071877878753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,14046,96,0.91 [0.71-1.17],0.4516624960000441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,16506,110,1.55 [1.03-2.32],0.0360336130914904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,16579,112,1.31 [0.95-1.82],0.1007274711696078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,16739,109,0.93 [0.75-1.15],0.5110324807461379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,16515,108,2.03 [1.22-3.39],0.0068130863807863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,16618,113,3.11 [1.85-5.23],1.9646879821979904e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,16695,107,1.70 [1.07-2.72],0.0256005911116511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,16019,108,1.60 [0.89-2.86],0.1166504015365093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,16547,113,1.94 [0.75-5.04],0.1729834167829617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,16012,103,1.70 [0.87-3.32],0.1196989316226682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,14419,98,1.71 [1.15-2.55],0.0086943408315299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,16714,109,1.13 [0.82-1.56],0.4595849692561758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,16395,104,1.07 [0.75-1.51],0.7193147997763805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,16505,111,0.99 [0.82-1.20],0.9392238498305678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,14012,94,1.07 [0.68-1.69],0.7623512234828467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,16536,110,1.10 [0.74-1.64],0.6270650231412636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14181,95,1.96 [1.33-2.91],0.0007580189516306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16696,107,2.25 [1.44-3.52],0.0003909936452381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,16739,109,1.76 [1.25-2.49],0.0013097497383439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14466,98,3.73 [2.41-5.76],3.0090336570584796e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,14209,95,0.42 [0.22-0.82],0.0108534977320714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,16536,110,1.79 [1.13-2.83],0.013526263868788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,16536,110,0.84 [0.49-1.44],0.5287443142703678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,14404,96,1.98 [1.04-3.75],0.0369561620813429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,16696,107,1.52 [1.13-2.06],0.0063715044751852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,15986,103,1.54 [0.90-2.64],0.1171808192918131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,16588,110,1.12 [0.48-2.62],0.787834173684037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,16588,110,1.17 [0.58-2.35],0.6684942222866416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,14438,98,0.78 [0.51-1.19],0.2433863466902758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,14454,97,0.62 [0.24-1.57],0.3111150916169659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,13971,93,0.92 [0.65-1.29],0.6257033841196911
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,13971,93,1.18 [0.76-1.85],0.4641568147274517
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,14374,96,1.16 [0.88-1.54],0.2900352060074582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,16222,104,0.85 [0.63-1.15],0.294815598980874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,16637,112,1.01 [0.83-1.24],0.8927241869873526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,14404,96,0.99 [0.82-1.20],0.9484305116429256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,16424,105,1.65 [1.25-2.20],0.0005098255689244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,16049,107,1.36 [0.93-1.99],0.1141702307307837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,16666,106,1.11 [0.88-1.41],0.3834858103972308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,16562,112,1.29 [1.03-1.62],0.027690878484385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,16562,112,2.40 [1.54-3.75],0.0001220705038451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,14209,95,0.84 [0.41-1.72],0.6268609609777289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,14454,97,0.56 [0.26-1.22],0.1461219590912131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,16696,107,1.24 [0.79-1.96],0.3508045722846341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,14023,89,1.06 [0.70-1.60],0.7701563859113504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,16779,112,1.33 [0.78-2.28],0.2978333797325311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,16562,112,2.41 [1.69-3.44],1.2806527879478898e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,16186,102,1.10 [0.74-1.63],0.6460918018123636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,16497,109,1.61 [1.25-2.08],0.0002335509176576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,16562,112,0.72 [0.48-1.08],0.115387107591958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,13971,93,1.07 [0.62-1.85],0.8003420926542795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,14444,95,1.25 [0.93-1.69],0.1329473982478895
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,14023,89,1.14 [0.81-1.61],0.4436925354560016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,16497,109,1.01 [0.86-1.19],0.9032358581779666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16497,109,1.01 [0.84-1.21],0.9249042670283156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,16497,109,1.04 [0.62-1.72],0.8910571894960638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16592,113,0.61 [0.34-1.08],0.0917369590583961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,16689,109,0.93 [0.63-1.37],0.7273939904713094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16610,112,5.56 [2.79-11.09],1.0631725861017536e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,14404,96,0.68 [0.54-0.87],0.0022456860224649
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,14209,95,0.97 [0.72-1.30],0.8231506108750067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,14404,96,0.96 [0.59-1.56],0.86645117407535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,14209,95,1.08 [0.71-1.64],0.7218642244440857
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16536,110,1.00 [0.82-1.21],0.963490126831034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,16222,104,1.37 [1.03-1.84],0.0333113950589218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,16032,102,1.16 [0.89-1.51],0.2854472490068127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14479,98,1.04 [0.63-1.69],0.88948208874573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,16271,105,1.13 [0.80-1.61],0.4902632643722105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,14046,96,0.98 [0.55-1.75],0.9439636157068176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,16271,105,0.95 [0.60-1.50],0.8250944543419345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,14479,98,0.82 [0.61-1.11],0.1920771409538468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,16755,112,1.26 [0.96-1.66],0.0946281889827432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,14181,95,0.86 [0.43-1.71],0.6658612607561408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,14046,96,1.53 [0.99-2.36],0.0551104268406592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,14023,89,0.96 [0.67-1.37],0.8217010042486249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,14209,95,0.92 [0.64-1.33],0.6567767031972336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,14209,95,1.21 [0.95-1.52],0.1171852055655016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,14003,91,1.35 [0.98-1.86],0.0684628148119813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,13971,93,1.35 [0.91-2.00],0.1410680862170533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,16279,105,0.87 [0.63-1.19],0.3714442116459711
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,14109,95,1.10 [0.85-1.43],0.473257882440582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,16222,104,1.16 [0.92-1.45],0.2090089048731921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,14209,95,0.81 [0.53-1.24],0.3308605135827449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,13971,93,1.17 [0.72-1.90],0.5307792783537139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,16147,104,1.11 [0.86-1.43],0.4082394514941024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,16222,104,1.02 [0.77-1.34],0.9023725621076484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,16186,102,0.98 [0.73-1.31],0.9027950254468804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,16627,110,1.39 [1.16-1.66],0.0003050367759435
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,16497,109,1.38 [1.05-1.83],0.0215843011997977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,16497,109,0.97 [0.76-1.24],0.7985214030041281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,16186,102,1.00 [0.77-1.30],0.9936704225382744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,14404,96,1.07 [0.83-1.38],0.6146374076128578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,14239,98,0.92 [0.50-1.70],0.7917036843713181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,16222,104,1.49 [1.06-2.08],0.0215969141738753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,14494,98,0.64 [0.25-1.68],0.3704325721979203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,13650,97,0.95 [0.40-2.28],0.9147078697827518
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,14388,96,0.68 [0.51-0.91],0.0106612106322002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,14468,98,0.93 [0.72-1.20],0.5686011772767994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,14288,97,0.53 [0.40-0.70],7.55604964793747e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,14494,98,0.75 [0.28-2.02],0.5702201209343838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,14494,98,0.49 [0.24-0.97],0.0403966106902969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,16588,110,1.41 [1.09-1.82],0.0081509812108687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,14485,98,0.90 [0.54-1.50],0.6760816895563739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,14096,95,1.39 [0.96-2.03],0.0822547341464427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,16562,112,1.28 [0.87-1.88],0.2126020968221525
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,16222,104,0.99 [0.74-1.33],0.9360919014537088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,14181,95,0.84 [0.57-1.23],0.3667965872402799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14454,97,2.14 [1.60-2.86],2.6578924843976375e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,14417,95,1.94 [1.20-3.13],0.0064532474097737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,16271,105,0.95 [0.55-1.62],0.8436756236848832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,14479,98,1.16 [0.98-1.39],0.0894108524327689
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,16641,105,1.27 [0.85-1.89],0.2494314739852808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,16263,106,1.42 [1.19-1.71],0.0001473663101827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,16663,110,0.94 [0.86-1.03],0.1591583086421796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,16644,110,0.96 [0.55-1.68],0.8779967695473797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,14096,95,1.11 [0.81-1.52],0.5066052333167295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,16424,105,1.00 [0.80-1.25],0.9905793695766768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,14466,98,0.95 [0.68-1.35],0.7863763342501977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,14023,89,1.01 [0.76-1.33],0.9666769134265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,16618,113,2.09 [1.26-3.47],0.0044119747061511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,16562,112,1.56 [1.10-2.21],0.0130973812950319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,14096,95,1.33 [0.85-2.07],0.2107172518252148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,16637,112,1.14 [0.87-1.50],0.3418561257082059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,14479,98,1.30 [0.90-1.89],0.1630640847456602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,14209,95,0.90 [0.56-1.44],0.6612567633214197
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,14404,96,1.09 [0.88-1.34],0.4270723291297861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,14096,95,1.37 [0.95-1.97],0.0888052998066548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,16675,108,2.31 [1.48-3.61],0.0002363263985022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,14479,98,1.40 [1.02-1.93],0.0379322458514026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16534,112,1.02 [0.79-1.31],0.8909320334108699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,13971,93,1.03 [0.79-1.34],0.82330798897793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,16533,112,1.10 [0.86-1.41],0.4380210679793458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,16424,105,0.88 [0.54-1.43],0.6119558126293467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,16558,109,1.23 [0.87-1.74],0.242766215743569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,14046,96,1.61 [0.66-3.95],0.2970369795250619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,16588,110,1.48 [0.90-2.43],0.1237248706188232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,16271,105,1.17 [0.70-1.93],0.5503872146495328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,16696,107,0.96 [0.80-1.15],0.6622991068837147
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,14096,95,1.06 [0.73-1.55],0.756321016817177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,14147,98,0.44 [0.22-0.88],0.0206302566390829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,16536,110,0.71 [0.45-1.14],0.1560804122366563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,16536,110,0.90 [0.63-1.28],0.548858362109129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,16536,110,1.22 [0.93-1.59],0.1460292306038223
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,16536,110,0.58 [0.35-0.97],0.0388462360425501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,14453,98,0.95 [0.64-1.41],0.7905927143094641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,16524,111,1.50 [0.87-2.59],0.1439102497012447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,16222,104,1.12 [0.77-1.63],0.5378641788478069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,16739,109,0.97 [0.74-1.27],0.8446566393749058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,14096,95,1.35 [0.94-1.94],0.1071569713748932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,14096,95,1.08 [0.60-1.96],0.8005737448601727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,13971,93,0.83 [0.51-1.34],0.4379521186789233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,16536,110,0.94 [0.81-1.09],0.4404409146757694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,16723,107,2.02 [0.94-4.35],0.0710385582022999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,14096,95,0.83 [0.45-1.53],0.5586698701774656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",16394,104,1.04 [0.87-1.25],0.6671152299019583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,16553,110,1.08 [0.86-1.37],0.4974650929944105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,16156,101,0.73 [0.40-1.34],0.3104259986166204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,16186,102,0.84 [0.59-1.21],0.3516875423510358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,16739,109,2.42 [1.76-3.31],4.191576755516194e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,14454,97,2.41 [1.43-4.08],0.0010320061906773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,16271,105,0.96 [0.66-1.41],0.8487956136548371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,14494,98,0.69 [0.26-1.80],0.4449667296005706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,16535,111,1.04 [0.72-1.52],0.8287206461814789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,14466,98,1.11 [0.90-1.37],0.3378761287200192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,14417,95,1.02 [0.81-1.29],0.8732437482529403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,16666,111,0.55 [0.41-0.74],8.91852102641357e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,14023,89,1.14 [0.83-1.57],0.4142251211761063
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",14082,95,1.12 [0.87-1.44],0.3660369083502106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,16271,105,0.80 [0.57-1.13],0.2090756535676979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,16497,109,1.01 [0.80-1.27],0.9423512384401008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,16562,112,0.98 [0.84-1.14],0.7467775737045786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,14023,89,0.96 [0.53-1.74],0.8936510814785845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,16779,112,1.31 [0.71-2.41],0.3864331446957504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,16723,107,1.51 [1.05-2.18],0.0281674385899392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,16588,110,1.39 [0.79-2.44],0.2583542668644683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,16588,110,1.72 [0.86-3.45],0.1257647245363279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,16596,104,1.48 [0.94-2.34],0.0901991037675326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,16536,110,1.89 [1.32-2.71],0.0004785649596132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,14096,95,1.10 [0.93-1.30],0.2728635725823536
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,14466,98,1.27 [0.85-1.91],0.2428772470058955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,14479,98,1.21 [0.60-2.43],0.6008365555399675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,16667,110,2.37 [1.19-4.74],0.0146658552295728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,16779,112,2.06 [1.08-3.93],0.0276226457458349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,14404,96,1.38 [0.96-1.98],0.0861021497638716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,14096,95,0.95 [0.73-1.23],0.6843691378962391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,14109,95,1.07 [0.84-1.37],0.5870497019707663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,14479,98,1.99 [0.92-4.32],0.0821726895129129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,16562,112,2.74 [1.95-3.87],7.789154286305313e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,14184,95,1.03 [0.71-1.50],0.8637274662383769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,14181,95,2.62 [1.77-3.87],1.5123800023182265e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,16779,112,1.86 [1.23-2.81],0.0031290267637563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,16536,110,1.06 [0.75-1.49],0.7439806487006593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,14209,95,0.82 [0.50-1.34],0.425474399838095
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,16564,113,1.70 [0.94-3.09],0.0791296129134774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,14109,95,1.21 [0.87-1.67],0.2542255974047819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,14417,95,1.44 [1.02-2.04],0.0401030517038363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,16415,108,1.43 [0.86-2.38],0.1640355760088112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,16110,102,1.13 [0.91-1.40],0.2791420525138622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',14003,91,1.08 [0.69-1.67],0.7455437211913631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,16186,102,0.77 [0.50-1.19],0.2350968115864417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14109,95,1.70 [1.28-2.25],0.000213723382836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,16231,107,1.06 [0.88-1.28],0.5284196794741451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,14023,89,0.91 [0.52-1.62],0.7581936147721214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16497,109,1.14 [0.90-1.44],0.2911394940902974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,14466,98,1.37 [0.78-2.42],0.2728815092528748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,16779,112,1.31 [1.01-1.68],0.0398810129220989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,16645,106,1.31 [1.03-1.67],0.0272001993113386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,13903,94,1.27 [0.79-2.03],0.3223539646298856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,16779,112,1.40 [1.09-1.81],0.0088482390520172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,14467,98,0.36 [0.15-0.84],0.0181973864586251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,16579,107,0.98 [0.63-1.51],0.916578074290849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,13971,93,1.11 [0.62-2.00],0.7153081486416177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,16605,105,2.05 [1.28-3.27],0.0028643184510355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",14046,96,0.80 [0.38-1.69],0.5570580172045094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,16696,107,1.13 [0.88-1.46],0.3397946635343552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,14446,98,1.53 [0.88-2.67],0.1308564004015251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,14003,91,0.97 [0.57-1.63],0.8950841434716595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,16702,107,1.45 [0.94-2.25],0.0915481800324699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,16637,112,0.87 [0.68-1.11],0.260927624900914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,14466,98,1.29 [0.64-2.61],0.4752471500742862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,14432,97,2.09 [1.24-3.52],0.0055854180891647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,16666,111,1.56 [1.10-2.21],0.0121876251846934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,16222,104,0.94 [0.76-1.16],0.5506209445900869
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,16394,104,0.99 [0.79-1.26],0.963133394171482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,13971,93,0.85 [0.57-1.26],0.4265009929313191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,13971,93,0.78 [0.35-1.74],0.550876690251877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,16386,111,1.63 [1.11-2.39],0.0124859269395763
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,14181,95,1.71 [1.01-2.87],0.0448199498937887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,16618,113,1.08 [0.79-1.49],0.6178199763215788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,16195,103,0.89 [0.72-1.11],0.3058875342934978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,16564,113,2.26 [1.24-4.12],0.0079209839575886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,16271,105,0.83 [0.60-1.13],0.2375160742217236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,16643,113,4.44 [2.09-9.45],0.000109237937359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,16424,105,1.38 [0.93-2.03],0.1109978802979217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,16723,107,0.95 [0.71-1.26],0.7240635126915344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,14357,98,0.39 [0.20-0.74],0.0040024791333344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,16601,113,1.04 [0.88-1.22],0.6623120390305044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,16643,113,1.18 [0.60-2.34],0.6256617189504241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,16144,105,0.92 [0.72-1.19],0.5350324198408456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,16779,112,0.89 [0.51-1.53],0.6652670414645099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,16424,105,1.33 [0.95-1.88],0.0972705039408582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,14096,95,1.33 [0.95-1.84],0.0944405433431994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,16271,105,0.96 [0.81-1.14],0.6232578531053139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,14466,98,1.15 [0.85-1.55],0.3705003108432126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,14454,97,1.18 [0.98-1.41],0.0737369264985239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,14454,97,1.19 [0.97-1.45],0.0940249758065797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,14023,89,0.98 [0.74-1.30],0.8837768366986747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,14109,95,1.15 [0.92-1.44],0.2139021397872634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,14003,91,1.12 [0.97-1.31],0.1305694686951928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,16643,113,2.74 [1.57-4.80],0.0004179564250687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,14485,98,2.13 [1.39-3.27],0.000527187659319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,14003,91,0.94 [0.53-1.66],0.825437671514558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,16424,105,1.33 [1.03-1.71],0.0299039335311227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,14046,96,0.92 [0.58-1.45],0.7145548038015539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,16279,105,0.97 [0.67-1.39],0.8594901410819026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,14046,96,0.87 [0.44-1.73],0.6885957416820919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,14485,98,1.40 [0.75-2.60],0.2887117858869333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,14046,96,0.92 [0.66-1.28],0.6225973156876703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,14444,95,0.96 [0.62-1.49],0.8588770710923654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,14479,98,1.50 [0.84-2.69],0.1735070704120449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,14023,89,1.21 [0.86-1.72],0.2743325964263861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,14003,91,1.01 [0.82-1.25],0.894429516241876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,12601,88,1.18 [0.98-1.43],0.0805603682509304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,16639,111,1.33 [0.76-2.33],0.3234961772489538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,16248,104,1.09 [0.80-1.48],0.6044644736467282
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,16139,106,0.98 [0.69-1.39],0.9204930299607962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,16604,112,1.03 [0.87-1.22],0.7278428537017108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,16354,109,1.44 [0.98-2.11],0.0641643691305605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,14185,95,0.97 [0.65-1.45],0.8908287684664589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,14263,97,0.80 [0.39-1.64],0.5432236913105268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,16271,105,1.13 [0.93-1.38],0.2144116889573683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,14479,98,1.33 [0.70-2.53],0.3801606317072235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,14479,98,0.88 [0.46-1.69],0.6977504258581715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,14023,89,0.89 [0.48-1.67],0.7224187898617149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,16588,110,1.23 [0.92-1.63],0.1588362193235887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,16572,113,1.17 [0.91-1.50],0.2278911035665374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,14454,97,0.80 [0.61-1.05],0.111048934544777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,16612,110,1.40 [1.04-1.89],0.0254982221289189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,16546,113,1.18 [0.82-1.70],0.3687287316786827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,15532,104,2.29 [1.78-2.95],1.6628223757709926e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,14181,95,1.21 [0.83-1.77],0.3226001266846432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,16637,112,1.24 [0.81-1.88],0.3186127663344361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,16214,105,0.92 [0.73-1.16],0.4738732678567237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,16562,112,2.59 [1.38-4.84],0.0029576141335391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,16739,109,2.43 [1.51-3.91],0.0002448417121116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,12955,72,3.34 [1.36-8.22],0.0085228318221232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,16669,107,0.85 [0.56-1.29],0.4503126070256525
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,16621,111,2.50 [1.53-4.10],0.0002699140123132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,14096,95,1.13 [0.69-1.83],0.6328054831312823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,14311,95,1.31 [1.02-1.68],0.0326281359618133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,16424,105,1.20 [0.73-1.99],0.4690605978249901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,16536,110,1.75 [1.32-2.32],9.248948324346413e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,16558,111,1.12 [0.95-1.32],0.1855679959035983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,16643,113,1.17 [0.92-1.48],0.2008357823400445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,16696,107,1.24 [1.04-1.48],0.0154191143396913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,16279,105,1.17 [0.75-1.81],0.4863030160757946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,16696,107,1.24 [1.01-1.51],0.0352066976655237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,16279,105,1.06 [0.80-1.42],0.6767519066566628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,16759,112,0.93 [0.45-1.89],0.8325107783634637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,16739,109,1.26 [0.85-1.87],0.2510632031426593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,16579,112,0.99 [0.83-1.18],0.90113443349106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,16512,112,1.06 [0.91-1.22],0.4635424937303017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,16739,109,1.22 [0.99-1.52],0.0680115159807949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,16479,107,1.50 [1.28-1.75],3.329689484902116e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,16643,113,1.07 [0.83-1.37],0.621980846605998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,13971,93,1.14 [0.90-1.44],0.2669090931696883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,14251,95,1.03 [0.72-1.47],0.8850146669227762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",14003,91,0.94 [0.73-1.20],0.615323829900309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,13971,93,0.95 [0.72-1.27],0.7462502126759494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,14479,98,1.01 [0.46-2.19],0.9808682924827088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,14181,95,1.08 [0.85-1.37],0.5049285267870247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,16723,107,1.00 [0.85-1.16],0.9705537722377175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,16643,113,1.46 [1.02-2.08],0.038872375580777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,14046,96,1.26 [0.96-1.66],0.0935350242640294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,14046,96,1.22 [0.90-1.67],0.2068567564642653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16536,110,1.01 [0.88-1.16],0.872482316181626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",16394,104,0.89 [0.70-1.13],0.3405700965886494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,14457,98,0.84 [0.73-0.98],0.0226580034335318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,16518,110,1.09 [0.87-1.37],0.4335728877522319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,14046,96,1.14 [0.77-1.69],0.5141246952969396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,16643,113,1.03 [0.86-1.23],0.7772618960208343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16637,112,1.24 [0.78-1.99],0.3625416161764128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,14096,95,0.81 [0.32-2.08],0.6641722793305105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,13971,93,1.16 [0.88-1.54],0.2898048141111989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,13971,93,1.37 [0.76-2.49],0.2970609529546301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,16271,105,1.13 [0.55-2.34],0.7351523557889239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,14181,95,1.09 [0.88-1.35],0.4149790383663622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,16723,107,0.84 [0.64-1.09],0.1861922503562077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,16497,109,0.88 [0.73-1.07],0.1991490777387762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,16186,102,1.01 [0.79-1.29],0.9307883088667632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,16562,112,1.73 [1.02-2.93],0.0428268434300969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,14023,89,1.19 [0.95-1.50],0.1329816726405073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,13971,93,0.99 [0.77-1.27],0.9443273985452556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,16637,112,1.48 [1.11-1.98],0.0080997945990113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,14003,91,0.95 [0.56-1.60],0.8410210029399228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16497,109,1.63 [1.15-2.32],0.0063420532443657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,16534,110,1.16 [0.81-1.64],0.4183442900652359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,14444,95,0.97 [0.72-1.31],0.8316838687961114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,14181,95,0.98 [0.76-1.26],0.8565211599307453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,16696,107,3.90 [2.03-7.47],4.1447869201083e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,14479,98,1.28 [0.82-1.97],0.2742764296919482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,14404,96,1.12 [0.77-1.63],0.5550574748082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,14096,95,0.73 [0.40-1.35],0.3143717973891843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,14046,96,2.06 [1.29-3.28],0.0023157596981932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,14046,96,0.82 [0.54-1.26],0.3693878122315998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,14096,95,0.74 [0.41-1.31],0.2981114405756813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,16222,104,1.22 [0.94-1.59],0.1415399633024055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16536,110,1.05 [0.88-1.25],0.5906704569479867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,16273,110,0.92 [0.66-1.27],0.5934731808239453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,13930,94,1.04 [0.66-1.63],0.8803540695781678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,14023,89,0.81 [0.53-1.24],0.332439296380996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,14023,89,1.03 [0.79-1.35],0.825493758784532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,14023,89,0.84 [0.54-1.30],0.4279758218295297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,16355,109,0.98 [0.88-1.10],0.7584825839856157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,14003,91,0.80 [0.49-1.30],0.361400126587613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,14046,96,1.09 [0.78-1.51],0.6087336714088574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,16739,109,1.07 [0.83-1.38],0.5923885636197499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,14023,89,1.43 [1.06-1.94],0.0206395410719226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,14046,96,1.25 [0.88-1.78],0.2059953540630596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,16279,105,0.98 [0.59-1.62],0.9360753540050256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,14003,91,1.07 [0.72-1.61],0.7297007738898078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,14417,95,1.35 [0.94-1.95],0.1068487794166778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,14454,97,1.28 [0.88-1.85],0.1965275329900714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",16524,111,1.04 [0.89-1.22],0.5916570883743586
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,14096,95,1.13 [0.73-1.77],0.5785530573903312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,14181,95,1.71 [0.90-3.26],0.1003916773824667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,16696,107,1.04 [0.78-1.39],0.7898215736080172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,16779,112,1.97 [1.14-3.40],0.0149742638496286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,16403,105,1.34 [0.94-1.90],0.1030516252544363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,16497,109,1.35 [1.07-1.70],0.010466276623434
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,14454,97,1.05 [0.80-1.38],0.7339512222681326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,14444,95,1.05 [0.73-1.50],0.8081837593176767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,16779,112,1.29 [0.96-1.74],0.0879873489928126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,16637,112,1.98 [1.19-3.31],0.0090629789911482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,14109,95,0.97 [0.77-1.23],0.8031038279721221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,14109,95,1.24 [0.87-1.77],0.2342558584835839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,14109,95,0.86 [0.63-1.18],0.3506122564072182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,13971,93,0.84 [0.52-1.36],0.4813113531267778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,16700,108,0.97 [0.79-1.20],0.7960992962941305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,14454,97,1.01 [0.77-1.32],0.938434909736451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,16497,109,0.98 [0.80-1.19],0.8254878131969344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,14404,96,1.21 [0.90-1.63],0.1994761292908146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,14181,95,1.10 [0.76-1.57],0.6197381521028705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,14045,94,1.12 [0.89-1.43],0.337924117936202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,16271,105,1.11 [0.84-1.46],0.4634504917381464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,14454,97,1.26 [0.78-2.04],0.3376234863437906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,14109,95,1.00 [0.78-1.26],0.9733896393930344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,14404,96,1.09 [0.85-1.40],0.5055443238975145
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,16539,113,0.91 [0.47-1.76],0.777520058142805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,14023,89,1.04 [0.84-1.30],0.7057684832605111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,14404,96,1.00 [0.84-1.18],0.9664325440485554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,14444,95,1.20 [0.86-1.67],0.2814463665795393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,16424,105,1.02 [0.76-1.37],0.890618041529292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,14454,97,1.51 [1.07-2.13],0.0187992640937568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16626,113,1.19 [0.87-1.64],0.2781978375176689
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,14096,95,1.20 [0.74-1.93],0.4594616882514376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,14023,89,0.97 [0.81-1.16],0.6992184912970755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,14454,97,1.03 [0.89-1.19],0.718517646300501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,16562,112,1.04 [0.91-1.19],0.5748998983380187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,16394,104,1.04 [0.73-1.49],0.8200910957254397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,16497,109,1.10 [0.62-1.94],0.7471712824559146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,16536,110,2.72 [1.96-3.78],2.1669884100860284e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,16314,106,1.55 [0.84-2.86],0.1647523348132286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,16497,109,1.54 [0.95-2.49],0.0774290856038918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,16439,112,1.45 [1.11-1.90],0.0066201886711164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,16779,112,1.93 [0.95-3.90],0.0689036881891421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,16664,107,1.33 [1.03-1.72],0.0271141074079789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,16424,105,1.26 [0.84-1.87],0.2614050985055113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,16497,109,1.06 [0.78-1.43],0.7255197036659157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,16411,110,2.17 [1.45-3.25],0.0001574094512307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,14444,95,1.80 [1.06-3.05],0.0302913046196962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,16588,110,1.10 [0.60-2.01],0.7560874591550893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,16667,107,0.79 [0.48-1.29],0.3463817865537346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,16442,109,0.79 [0.56-1.12],0.1895710590717033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,14181,95,1.03 [0.82-1.29],0.8099572904025945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,14387,95,2.10 [1.44-3.06],0.0001073702878634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,14096,95,0.81 [0.56-1.18],0.2765089339736672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,16497,109,1.71 [0.87-3.35],0.1185305740615356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,14466,98,1.07 [0.81-1.43],0.6284959935179819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,16271,105,0.85 [0.64-1.12],0.2383237680879638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,14417,95,1.15 [0.73-1.79],0.5512735517082196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,14096,95,0.91 [0.66-1.25],0.5463106541788492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,16186,102,0.90 [0.72-1.12],0.3269331702341125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",14404,96,1.16 [0.96-1.40],0.1177153341263815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,14454,97,1.34 [0.88-2.04],0.166149315357119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,14417,95,1.06 [0.71-1.60],0.7744533167733574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,14096,95,1.14 [0.90-1.44],0.2725320941499004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,14417,95,1.06 [0.68-1.65],0.8055107175758849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,16424,105,0.98 [0.81-1.17],0.7875660310879585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,16693,107,1.80 [1.04-3.11],0.0370930735399507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,16186,102,1.38 [0.92-2.07],0.1204123198236206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",14466,98,1.41 [1.13-1.76],0.0020848649401212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",14109,95,1.33 [1.09-1.61],0.0046402809001471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,14003,91,1.17 [0.86-1.59],0.3251020317469043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,14109,97,1.07 [0.63-1.84],0.7978672377563083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,14023,89,0.64 [0.38-1.10],0.1052300339481533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,16723,107,2.37 [1.62-3.45],7.724790357234023e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,16536,110,0.96 [0.79-1.16],0.6438004366077257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,14417,95,1.15 [0.81-1.65],0.4334724689599973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,14003,91,0.63 [0.32-1.24],0.1823927946149228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,14444,95,1.21 [0.94-1.54],0.1379023705363078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,16271,105,0.70 [0.41-1.18],0.1808150821651598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,14109,95,1.75 [0.91-3.37],0.0933122384869019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,14046,96,1.04 [0.67-1.63],0.8552845315391167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,14466,98,1.12 [0.91-1.38],0.2947216854687822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,14404,96,1.61 [1.04-2.51],0.0341678632035591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,14209,95,1.67 [1.01-2.75],0.0454498377700293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16646,111,2.31 [1.40-3.82],0.0010456462826955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,14444,95,1.17 [0.69-1.98],0.5529942093834267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,16567,110,1.67 [0.97-2.87],0.0625159321327377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,16395,104,2.28 [1.42-3.67],0.00067711480333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,14096,95,1.20 [0.88-1.63],0.2611844739249626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,16554,112,0.98 [0.84-1.16],0.8511665769546919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,16222,104,1.24 [0.82-1.88],0.3003579281670194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,14404,96,1.49 [0.83-2.70],0.1842276562610555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,16779,112,0.42 [0.20-0.90],0.0249658717027151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,16536,110,1.27 [1.00-1.60],0.050414315878335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,14466,98,1.09 [0.84-1.41],0.5155345547210902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,14109,95,1.03 [0.87-1.22],0.7234748969419813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",14454,97,1.20 [0.88-1.64],0.2504621654683321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",14341,95,1.12 [0.94-1.34],0.1962521158641077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,14003,91,0.96 [0.70-1.32],0.8197752103428373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,14109,95,1.57 [1.06-2.34],0.0255189290219559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,16424,105,1.09 [0.80-1.48],0.5877482143662993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,14046,96,1.08 [0.86-1.34],0.5156247113020973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16562,112,1.22 [0.95-1.55],0.1206979230640134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16739,109,1.03 [0.87-1.23],0.7191580487346538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,14444,95,1.05 [0.78-1.42],0.7548594041874748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,14003,91,0.79 [0.48-1.31],0.3646065629504817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,16279,105,0.85 [0.46-1.57],0.5998407158417864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,14444,95,1.08 [0.85-1.36],0.5439435927504752
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,14023,89,1.16 [0.93-1.44],0.2015030645977316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,14466,98,1.51 [0.90-2.54],0.119492093756972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,16497,109,1.27 [0.98-1.64],0.0690893215785835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,14003,91,0.81 [0.46-1.44],0.4751989082043547
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,16279,105,1.19 [0.83-1.69],0.3410234856735303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,13335,92,0.62 [0.43-0.91],0.0137756305960574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,16779,112,4.83 [2.20-10.58],8.323135662772939e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,16537,105,1.07 [0.86-1.34],0.5222665055979074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,16696,107,1.00 [0.77-1.31],0.981835732577498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,14109,95,1.13 [0.82-1.55],0.4652002659020663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,14417,95,1.30 [1.01-1.66],0.0389690703992176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,14003,91,0.56 [0.26-1.24],0.1557186900894522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,14003,91,0.87 [0.52-1.43],0.5759367504483104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16779,112,4.03 [2.38-6.82],2.095286958764961e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16643,113,0.81 [0.57-1.15],0.243704954527188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,14109,95,1.03 [0.59-1.78],0.9298677121588262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,16012,107,1.47 [1.20-1.80],0.0001979841687178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,14417,95,1.05 [0.73-1.52],0.7848986857676314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,16222,104,1.62 [1.17-2.24],0.0033777172696828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,16271,105,0.54 [0.25-1.18],0.1218528939809213
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,16271,105,1.34 [0.69-2.62],0.3903023452175467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,14109,95,1.44 [1.09-1.92],0.0115371394858631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,14046,96,1.15 [0.64-2.05],0.6437047762360513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,14096,95,0.92 [0.65-1.29],0.6315029378916216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,16559,113,1.05 [0.88-1.24],0.5898556639709551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,14417,95,0.97 [0.62-1.53],0.9106768858920088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,16626,113,1.24 [0.73-2.08],0.4277193150408611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,16186,102,0.90 [0.67-1.20],0.4748979605525358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,15996,106,2.12 [1.44-3.13],0.0001285323990978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,14181,95,1.38 [0.71-2.72],0.343968285048338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,16779,112,2.65 [1.46-4.78],0.0012938430264986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,16394,104,1.40 [0.83-2.36],0.2077542231882113
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,16271,105,0.99 [0.75-1.32],0.9626859366296872
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,14209,95,1.20 [0.81-1.78],0.3571451120566766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16536,110,1.23 [1.00-1.51],0.0528659425567489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,14109,95,1.23 [0.94-1.60],0.1297782102772667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16694,107,2.52 [1.53-4.15],0.0002944156398473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,16637,112,2.65 [1.33-5.29],0.0054501937166989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,16536,112,0.94 [0.39-2.25],0.880663954364069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,16637,112,1.48 [0.74-2.94],0.2694496392077251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,16497,109,0.97 [0.82-1.15],0.7175042098632066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,14096,95,0.91 [0.68-1.21],0.4990596210974771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,13971,93,0.83 [0.43-1.59],0.565270520531109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,16394,104,0.94 [0.75-1.18],0.6052203087329027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,14209,95,1.28 [0.74-2.21],0.3767139927725109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,14046,96,0.91 [0.58-1.42],0.6799538598976922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,14417,95,1.13 [0.68-1.90],0.6341784035815645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,14181,95,1.07 [0.90-1.26],0.4346891681270488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,16465,109,0.82 [0.42-1.59],0.5499671963027208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,14003,91,0.95 [0.59-1.54],0.8488578510281847
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,16779,112,1.61 [0.98-2.64],0.0618293342891937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,16564,113,1.51 [0.93-2.45],0.0949269556133565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,13971,93,1.03 [0.73-1.45],0.865119920080961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,14046,96,0.63 [0.38-1.02],0.0598276093063676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,14454,97,1.10 [0.87-1.40],0.4109770703987041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,13971,93,0.82 [0.47-1.44],0.4891456055237739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,14046,96,1.19 [0.96-1.47],0.1174721916225591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,14209,95,1.52 [0.95-2.43],0.0823228924290588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,14003,91,0.86 [0.57-1.28],0.4552122037967497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,14003,91,1.03 [0.69-1.55],0.8814665008191033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,16696,107,1.60 [0.81-3.19],0.1775100826567686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,14485,98,0.43 [0.24-0.75],0.0032429215972827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,14290,98,0.48 [0.29-0.79],0.0035294706315038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,16588,110,0.99 [0.73-1.35],0.9596279837643052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,14494,98,0.86 [0.55-1.35],0.5123935191188066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,14419,98,0.73 [0.34-1.54],0.4033052623262306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,14494,98,0.40 [0.15-1.02],0.0551746722489339
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,16618,113,1.20 [0.90-1.62],0.2183626272356176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,16624,107,1.64 [0.88-3.05],0.1185154395859978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,16647,110,0.62 [0.37-1.05],0.0738029412715947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,16634,109,0.59 [0.23-1.51],0.2725500006378675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",16564,113,1.23 [1.04-1.45],0.0147971170992577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",16562,112,0.94 [0.76-1.16],0.539014376093994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",14466,98,1.24 [0.87-1.78],0.2370819001432038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",16779,112,1.42 [1.05-1.93],0.0230427194604506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,16636,107,1.07 [0.83-1.38],0.6030487843419096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,16241,105,0.86 [0.63-1.18],0.3586466882623227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,16536,110,0.79 [0.58-1.08],0.1407530231690492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,16562,112,1.13 [0.90-1.40],0.2914676849176435
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,14404,96,0.99 [0.74-1.33],0.9634543789692812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,14444,95,1.17 [1.06-1.30],0.0027010153518281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,14417,95,1.00 [0.49-2.05],0.9986043012907628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,14109,95,1.12 [0.81-1.55],0.4996373378615166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,14466,98,1.08 [0.54-2.14],0.8284651882807328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,16497,109,1.61 [0.97-2.66],0.0637287520681005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,16534,110,1.45 [0.84-2.51],0.176261879109378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,14404,96,1.17 [0.93-1.46],0.1758808356978203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,16779,112,1.45 [0.78-2.68],0.2370188983889294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,14096,95,1.13 [0.87-1.46],0.3666668331645836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,16740,111,1.64 [1.21-2.22],0.0015675159449363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,16739,109,1.04 [0.65-1.64],0.8820731012259682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,14479,98,2.34 [1.35-4.07],0.002430659290214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,14096,95,0.99 [0.71-1.38],0.9385631295889784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",16562,112,1.36 [1.10-1.67],0.0037078557268453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14466,98,1.61 [1.26-2.07],0.0001796099132863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,16536,110,1.20 [0.85-1.70],0.2948573691084799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,14444,95,0.86 [0.37-1.96],0.7141166664803129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,16588,110,1.61 [1.18-2.20],0.0029184669876372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16536,108,0.96 [0.73-1.26],0.784171347529597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16222,104,1.27 [0.96-1.68],0.1003945950890756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16620,109,0.96 [0.68-1.35],0.811273183606677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,14457,98,0.95 [0.68-1.32],0.7388924026971149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,16525,109,0.48 [0.34-0.67],1.5475224843168654e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,16562,112,1.61 [1.14-2.27],0.0062611528610816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,16654,108,1.31 [0.94-1.82],0.1078730304344469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,16279,105,1.40 [1.03-1.91],0.0303735654186864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,16588,110,1.26 [0.94-1.68],0.1215227909362079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,16536,110,1.11 [0.87-1.42],0.3832456669614378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,16222,104,1.36 [1.09-1.69],0.0058916400047144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",14003,91,1.16 [0.87-1.54],0.3153785327476168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",14003,91,0.91 [0.62-1.32],0.6098519803196407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,16222,104,1.09 [0.86-1.38],0.4687278394935625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,16222,104,1.01 [0.70-1.47],0.9383814510126788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,16634,109,0.63 [0.46-0.87],0.005327992836204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,14157,98,0.87 [0.46-1.66],0.6761953828016547
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",14444,95,1.13 [0.89-1.45],0.311724179194743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,14046,96,0.32 [0.14-0.72],0.0058059673488226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,14046,96,0.81 [0.51-1.29],0.3737158867925719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,16643,113,1.13 [0.92-1.40],0.2473502099055712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,16536,110,1.15 [0.91-1.47],0.2420083421578294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,14046,96,0.57 [0.32-1.03],0.0641231781652745
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,16693,107,1.23 [1.07-1.40],0.0033336925987792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,16699,107,1.17 [0.88-1.56],0.2800524981243422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,14046,96,1.10 [0.61-2.00],0.7413098099645727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,16279,105,1.46 [0.89-2.41],0.1358548208002458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,14046,96,0.78 [0.44-1.37],0.3812430548835275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,13971,93,1.09 [0.87-1.38],0.4524823977750666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,13949,93,0.99 [0.61-1.63],0.9785411687541729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,16637,112,0.40 [0.25-0.65],0.0002055270201705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,14479,98,0.75 [0.51-1.11],0.1543905750972901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,14454,97,1.10 [0.65-1.86],0.7337812300746005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,16637,112,7.21 [3.85-13.50],6.657540166425765e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,14181,95,1.00 [0.68-1.46],0.9923064491096292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,14485,98,1.35 [1.01-1.82],0.0444964031627087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,16186,102,1.01 [0.76-1.35],0.9230323971340976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",14023,89,0.85 [0.63-1.14],0.2772866793129533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,14003,91,0.82 [0.52-1.31],0.409875500883837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,16186,102,0.98 [0.77-1.24],0.8443951794188309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,16587,112,1.06 [0.85-1.32],0.6174915009934288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,14444,95,1.02 [0.84-1.24],0.8386542434242531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16604,109,0.99 [0.85-1.15],0.8985085403287141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,16424,105,1.22 [0.81-1.84],0.3321499391970366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,16424,105,1.02 [0.84-1.22],0.8738968574639889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,16156,101,1.03 [0.70-1.51],0.8772049550567307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,14404,96,1.04 [0.74-1.44],0.8356452954614004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,16222,104,1.03 [0.88-1.20],0.7567290711981105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,16424,105,1.44 [0.79-2.62],0.2317820009906216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,16461,109,1.31 [0.61-2.81],0.4874598650394969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,16222,104,1.13 [0.65-1.97],0.6552762989953359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,16739,109,1.13 [0.68-1.86],0.634256624965754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,16637,112,0.85 [0.52-1.39],0.5101071446783993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,16186,102,1.09 [0.86-1.39],0.4745817194467404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,16222,104,0.94 [0.57-1.55],0.7948077404998678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,14494,98,0.72 [0.35-1.51],0.3887771927586153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,14454,97,1.60 [1.06-2.42],0.0265774536908609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,14417,95,1.13 [0.64-1.97],0.6774924370622066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,14046,96,0.79 [0.60-1.06],0.1141970297236019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,16567,112,1.52 [0.88-2.64],0.1343458954107426
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,16696,107,2.09 [1.19-3.67],0.010295071468102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,16585,112,1.14 [1.06-1.22],0.0004603614471555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,13949,93,0.89 [0.50-1.56],0.6749587795999858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,16186,102,1.02 [0.64-1.62],0.9333210027108296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,14046,96,1.32 [0.89-1.97],0.1646501759724983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,16536,110,1.00 [0.82-1.22],0.9912180725413744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,16222,104,0.92 [0.76-1.12],0.4253387776869723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,14003,91,0.85 [0.62-1.16],0.3170051624622245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,14096,95,1.11 [0.62-1.98],0.7245998839556806
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,16368,104,1.89 [0.90-3.95],0.0914601592908013
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,14109,95,1.15 [0.79-1.68],0.4533082263533288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,16618,113,1.08 [0.77-1.52],0.6601131592037475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,14109,95,2.58 [1.23-5.39],0.0117035896142008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,16536,113,3.34 [2.20-5.07],1.6169806805797752e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,14424,97,1.33 [1.09-1.63],0.0055562054324972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,16691,111,1.10 [0.89-1.35],0.3937580877888817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,14181,95,1.55 [1.17-2.04],0.0019948637862456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,16637,112,1.05 [0.63-1.77],0.8388317801318951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,16199,104,1.26 [0.82-1.92],0.2947615852911088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",14174,95,1.08 [0.80-1.46],0.6145401692151653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16696,107,1.90 [1.34-2.68],0.0002863090165966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",16424,105,0.82 [0.61-1.12],0.2087712216312235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",16723,107,1.07 [0.85-1.35],0.5835171311141514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,16279,105,1.08 [0.83-1.41],0.5653365616398656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,16553,110,0.97 [0.81-1.16],0.7203842569783895
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,14096,95,1.12 [0.84-1.49],0.4490617740840373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,14023,89,1.06 [0.68-1.64],0.8093464404183953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,14417,95,1.01 [0.67-1.51],0.9742903519872648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,14209,95,1.11 [0.85-1.45],0.4465605606754512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,14023,89,1.11 [0.82-1.51],0.4956370780726611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,13971,93,0.72 [0.33-1.56],0.4040459772806281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,14046,96,0.63 [0.37-1.09],0.0975883868346009
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,14209,95,1.09 [0.77-1.54],0.6377928444962344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,14109,95,1.22 [0.85-1.76],0.2727417150632339
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,13971,93,0.98 [0.72-1.33],0.8832936574783865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,16643,113,0.74 [0.57-0.96],0.0212538758958677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16497,109,1.80 [0.99-3.27],0.0539888093935969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16723,107,1.94 [1.03-3.65],0.0387587862861357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16279,105,1.23 [0.84-1.82],0.2896017653830025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14466,98,0.78 [0.39-1.56],0.4823950866678913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,16497,109,1.29 [0.57-2.92],0.5418128227281829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,14003,91,1.59 [1.10-2.29],0.0138481130631023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,13860,94,1.24 [0.65-2.35],0.5202738941517651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,14444,95,1.00 [0.47-2.11],0.997624171607726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,14209,95,1.07 [0.75-1.54],0.6982653188234647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,16689,111,1.95 [1.00-3.81],0.0485911267371333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,14003,91,0.65 [0.41-1.05],0.0757611542778917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,14454,97,1.07 [0.95-1.22],0.25963683774472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,13971,93,0.82 [0.38-1.75],0.6079193803184897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",14109,95,1.30 [1.02-1.67],0.037034726682692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,14096,95,1.07 [0.75-1.52],0.7144854869782178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,14427,96,1.46 [1.11-1.93],0.0075905185768516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,16279,105,1.09 [0.82-1.45],0.5440663867579567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,16186,102,0.77 [0.53-1.14],0.1926520261408831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,14003,91,1.38 [1.01-1.89],0.0425225723284676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,14494,98,0.49 [0.23-1.06],0.068615313134815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,14454,97,1.11 [0.93-1.34],0.2501124968185461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,16222,104,1.04 [0.91-1.20],0.544915064749838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13846,91,1.61 [1.21-2.12],0.0009298154684217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,14003,91,0.72 [0.43-1.20],0.2094030468324326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16497,109,1.20 [0.74-1.97],0.4562193026777026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,16779,112,2.38 [1.83-3.09],7.837844071135272e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,16562,112,0.94 [0.59-1.49],0.7800093415884148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,16186,102,1.49 [0.98-2.27],0.0604172806190195
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,14466,98,1.10 [0.78-1.56],0.571280581753952
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,16190,104,0.84 [0.58-1.21],0.3455310046121017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,16222,104,1.25 [0.95-1.63],0.107574134452647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,16222,104,1.06 [0.94-1.21],0.3530632317865156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,16693,107,1.41 [0.79-2.51],0.2398201447407283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,16497,109,1.69 [0.79-3.62],0.1785388118961866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,16383,105,0.98 [0.53-1.81],0.9482660506060347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,14009,95,0.92 [0.66-1.27],0.6019612808105084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,16186,102,1.04 [0.80-1.34],0.7919246873037558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,14466,98,1.02 [0.78-1.34],0.8783153783172521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,14433,98,1.07 [0.71-1.61],0.7486583456483211
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,16338,109,1.39 [0.86-2.24],0.1764637205510557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,16567,110,2.25 [1.77-2.88],7.206992729100067e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,16424,105,2.20 [1.15-4.22],0.0175961246833044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,16534,110,1.06 [0.97-1.17],0.2106785826351478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,16222,104,0.92 [0.82-1.04],0.1793508496740289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,14181,95,0.63 [0.31-1.28],0.201928568435586
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,16186,102,0.95 [0.67-1.32],0.7426148460315558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,16562,112,0.92 [0.76-1.12],0.3997215702652001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,14444,95,1.43 [0.96-2.13],0.0792443805610018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,14444,95,1.09 [0.84-1.41],0.5283947781040346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,14181,95,1.20 [0.67-2.15],0.5346472901629411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,13971,93,1.50 [1.17-1.93],0.0015511796571123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,14109,95,1.11 [0.80-1.54],0.5283561334580035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,14454,97,2.13 [1.25-3.62],0.005419757009398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,14404,96,0.91 [0.75-1.11],0.3658865838600085
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,14046,96,0.76 [0.46-1.24],0.2655545787787792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,14046,96,0.98 [0.80-1.21],0.865117775328562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,13971,93,0.91 [0.64-1.27],0.5673663872126977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,15881,99,0.56 [0.30-1.06],0.0765805128245177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,14157,95,1.87 [1.17-3.01],0.0094122955345834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,16424,105,1.25 [0.83-1.88],0.280583719745696
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,14046,96,0.48 [0.23-1.00],0.0491099504139437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,16271,105,1.32 [0.99-1.76],0.0600405330071727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,16562,112,1.21 [0.75-1.96],0.4406202327835613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,14023,89,0.52 [0.26-1.02],0.0578460009851251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,16444,112,1.23 [0.93-1.64],0.1468692581167738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",14181,95,1.18 [0.95-1.47],0.1448234765222177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,16186,102,1.07 [0.74-1.54],0.7272620466317984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,14417,95,1.11 [0.81-1.53],0.5078400076441183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,14119,96,1.59 [1.16-2.19],0.0039953138171092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,14466,98,1.07 [0.82-1.41],0.6081768572520956
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,16739,109,0.97 [0.69-1.36],0.8455192343490016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,14181,95,1.16 [0.87-1.56],0.3089187613314628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,14444,95,0.98 [0.78-1.24],0.885553491235124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,16222,104,1.02 [0.78-1.33],0.9020098133558824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,14096,95,0.83 [0.53-1.30],0.4279506432087636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,16588,110,1.32 [0.97-1.79],0.0755229304637096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,14109,95,1.10 [0.65-1.87],0.724578418405871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,14181,95,0.84 [0.49-1.46],0.5439150892509289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,14444,95,1.02 [0.79-1.31],0.8893349831883843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,16696,107,2.06 [1.15-3.70],0.0158432434606106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16536,110,1.03 [0.87-1.22],0.6918291785082937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,14404,96,1.57 [1.08-2.29],0.0191158871701717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",14479,98,1.89 [1.40-2.55],3.248533875493808e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,16525,109,0.87 [0.52-1.47],0.6052265572065576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,14003,91,1.13 [0.84-1.52],0.433516765453999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,16077,102,0.97 [0.79-1.20],0.8041539765320341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,14181,95,0.84 [0.49-1.44],0.5235200431134972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,16553,110,1.00 [0.82-1.21],0.9736050310862786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,16497,109,1.00 [0.88-1.13],0.9974747523874468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,16723,107,1.52 [0.86-2.69],0.1530550264446383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,16424,105,0.99 [0.73-1.35],0.9635660108796152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,14417,95,1.57 [1.13-2.16],0.0066704792249913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,14404,96,1.28 [0.90-1.83],0.1753923185503864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,14485,98,1.61 [1.10-2.36],0.0141323867816155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,14404,96,1.18 [0.88-1.58],0.2814952546291183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,16186,102,1.27 [0.78-2.07],0.3374712074069473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,16112,106,1.95 [1.08-3.55],0.0277649894700821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,14023,89,0.72 [0.46-1.14],0.1610488154478712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,14444,95,0.85 [0.47-1.54],0.5915926900759041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,14404,96,1.06 [0.77-1.47],0.7010008396891007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,16271,105,1.09 [0.84-1.41],0.5197197933873778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,14417,95,1.85 [1.49-2.29],3.1430121300544475e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,16562,112,1.05 [0.92-1.19],0.5069198654860299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,14466,98,1.22 [0.90-1.66],0.2067453817396109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",14444,95,0.94 [0.60-1.47],0.795441905139514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",14023,89,0.97 [0.66-1.42],0.8746216609582704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,16271,105,1.33 [1.00-1.77],0.0465334221804615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,16511,110,3.87 [2.06-7.27],2.56477295034713e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,14109,95,0.99 [0.69-1.42],0.9539030322162756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",16497,109,1.85 [1.49-2.29],3.0641777268357305e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,13895,93,1.28 [1.02-1.60],0.0330672047426771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,16222,104,1.08 [0.90-1.30],0.4209159295903271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,14434,98,0.59 [0.29-1.22],0.1529023066872246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",14402,97,1.74 [0.73-4.16],0.2132949181240806
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,16533,112,1.30 [1.08-1.56],0.0054366551968134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,16222,104,1.15 [0.93-1.42],0.2081093272669821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,14003,91,1.10 [0.86-1.41],0.4424723225820858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,16090,102,0.85 [0.65-1.12],0.2521444550970427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,14454,97,1.07 [0.98-1.16],0.1261953235189993
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,14209,95,1.13 [0.89-1.43],0.3151018408090366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,14096,95,0.95 [0.74-1.22],0.6733045424950099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,16496,109,1.20 [0.75-1.94],0.4464491013665492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,14209,95,1.02 [0.80-1.29],0.8947671096445762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,14003,91,0.58 [0.30-1.11],0.1018310611471886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,16674,110,1.37 [1.07-1.75],0.0131195520931732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",16271,105,0.97 [0.81-1.18],0.7900159359988519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,16739,109,1.37 [0.85-2.20],0.1971531036559744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,16536,110,0.80 [0.60-1.06],0.1259231651261571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,16271,105,1.23 [1.03-1.47],0.021677532449052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,13971,93,0.61 [0.35-1.07],0.0853195952663506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",14003,91,0.89 [0.64-1.24],0.4941919021815133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16665,107,1.06 [0.84-1.34],0.6135225229963521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,16723,107,1.35 [1.19-1.52],2.65696328331034e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",16588,110,1.00 [0.80-1.24],0.9794203897010676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,16695,107,1.73 [1.37-2.18],4.6805444710040695e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,16588,110,2.69 [1.80-4.04],1.6669039843387578e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,16665,107,0.93 [0.74-1.18],0.5522722666637951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,16723,107,1.07 [0.81-1.41],0.6247866554866697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,14466,98,1.00 [0.84-1.20],0.9583910701265054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,14003,91,1.00 [0.70-1.43],0.9856912931190928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,16739,109,1.01 [0.74-1.38],0.933373326195184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,14046,96,0.67 [0.42-1.07],0.0943761334018126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,14023,89,0.94 [0.68-1.31],0.7302794445269291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,14404,96,1.28 [0.83-1.95],0.2633959730788169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,16689,107,1.10 [0.92-1.32],0.2962073927748172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,14454,97,1.20 [0.89-1.61],0.2295519948922047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,16271,105,0.92 [0.66-1.29],0.632274605602251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,14181,95,2.51 [1.22-5.15],0.0119346272813804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,14454,97,0.92 [0.59-1.46],0.7349826950210057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,14466,98,1.27 [0.60-2.66],0.5328669758741962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,16536,110,0.99 [0.80-1.22],0.8957712414624406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,16739,109,3.40 [2.31-5.00],5.385077330388665e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,14348,97,0.82 [0.44-1.53],0.5265412509720464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,16222,104,1.10 [0.88-1.38],0.3875603736790382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,14454,97,1.11 [0.86-1.43],0.4321452801749725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,14046,96,1.02 [0.74-1.39],0.9117831023936422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,14003,91,1.46 [0.94-2.28],0.0948454024970696
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,14418,97,1.85 [1.46-2.34],3.697590957321655e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,14444,95,0.98 [0.62-1.56],0.9356501280680998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,16271,105,1.18 [0.63-2.20],0.6111794177070593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",14444,95,0.95 [0.53-1.73],0.8783689355018343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16490,109,1.48 [0.95-2.30],0.083515822878838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16536,110,1.07 [0.61-1.88],0.8149901700820712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,16723,107,1.26 [0.84-1.87],0.2594096125416194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,14156,94,1.10 [0.78-1.56],0.5878135921608962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",14109,95,1.45 [1.01-2.10],0.0468366136137355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",14003,91,1.30 [0.89-1.91],0.1738931678487253
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,13941,93,0.85 [0.54-1.34],0.4833510468477593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,16388,109,1.24 [0.88-1.75],0.2186815054541473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,16186,102,1.48 [1.11-1.98],0.0084667050178329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,14096,95,1.12 [0.88-1.41],0.3656111928173864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,16341,102,1.68 [1.19-2.38],0.0033605637004023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,16227,105,1.13 [0.90-1.41],0.2830950401110312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14444,95,1.25 [0.88-1.79],0.213009267957578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,16739,109,1.00 [0.79-1.26],0.9797946601492676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,16222,104,0.81 [0.51-1.31],0.3929729404210824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,14286,97,1.11 [0.90-1.38],0.3151621943728001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,14173,95,0.77 [0.58-1.03],0.0783396295857126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14109,95,1.01 [0.56-1.82],0.9714833255600412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,14419,98,1.13 [0.61-2.09],0.7032689327169026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,14109,95,1.15 [0.92-1.43],0.2348404814651168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16497,109,0.99 [0.63-1.56],0.9745030479576534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16723,107,1.33 [0.89-2.00],0.1692258694597667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,14046,96,1.10 [0.63-1.92],0.739894910811423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,14109,95,1.11 [0.90-1.37],0.3452078158445251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16536,110,1.29 [0.85-1.96],0.2343459801583085
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,14454,97,1.04 [0.77-1.42],0.7874669254397028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,14003,91,0.96 [0.63-1.46],0.8531285977947396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,14109,95,1.09 [0.72-1.63],0.6949728592664105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,16105,102,0.70 [0.48-1.02],0.0606845838835922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,16626,113,1.06 [0.84-1.35],0.6055161165304699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,14417,95,1.27 [0.74-2.18],0.3862817414174645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,16323,111,1.10 [0.85-1.42],0.4653952096280972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,16723,107,1.20 [0.78-1.85],0.40313745793404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,16481,108,1.84 [1.04-3.26],0.0351873385457917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,14023,89,1.07 [0.83-1.36],0.6031167355665903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,14023,89,0.88 [0.54-1.45],0.6256296157441845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",16637,112,1.28 [0.98-1.67],0.0742354034516488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,16513,110,1.85 [0.93-3.66],0.078761823319534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,16779,112,1.09 [0.53-2.24],0.8059912354843345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,16279,105,1.03 [0.82-1.28],0.8187295283470366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16530,108,2.90 [1.79-4.69],1.4645233450430368e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,16779,112,1.55 [0.92-2.61],0.0968755508179167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,16779,112,1.91 [1.02-3.57],0.0433701423665625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,16536,110,1.07 [0.77-1.47],0.685706575276249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,16562,112,1.44 [0.99-2.08],0.0556950480187382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,16497,109,1.33 [0.55-3.21],0.5217567856199403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,14209,95,0.84 [0.51-1.40],0.5062430024291603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,16186,102,0.84 [0.57-1.23],0.3668016763720561
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",14109,95,1.11 [0.82-1.51],0.4894243416560294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,16739,109,0.46 [0.08-2.81],0.4012379375614505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,16723,107,1.43 [0.98-2.08],0.063776388040148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14039,96,2.09 [1.36-3.21],0.0007402639936485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,14209,95,1.40 [1.02-1.91],0.0345052360887227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,14209,95,1.59 [1.02-2.46],0.0393218521903462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,14404,96,1.13 [0.54-2.40],0.7425712515792381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,16279,105,1.07 [0.91-1.25],0.4194970481126507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,16643,113,2.92 [1.56-5.48],0.0008526290380514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,16424,105,1.33 [0.97-1.82],0.074729971006276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,16186,102,1.38 [0.97-1.97],0.0716016189272203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,14023,89,0.95 [0.67-1.35],0.792815597482672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,16536,110,1.10 [0.69-1.75],0.6863709748543757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,14003,91,0.74 [0.38-1.44],0.3794569119663395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,14096,95,1.10 [0.70-1.72],0.6782109758757355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,14444,95,1.09 [0.79-1.51],0.5819066225861766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,14023,89,0.74 [0.44-1.27],0.2745892702690533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14479,98,0.88 [0.43-1.80],0.7232612896587298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,16497,109,1.89 [0.92-3.90],0.084594156754839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,14003,91,1.06 [0.69-1.63],0.7954798926845171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,16588,110,1.15 [0.56-2.38],0.699956639739699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,16756,111,1.09 [0.95-1.25],0.2278695102049342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,16757,112,1.16 [0.89-1.52],0.2690754018512145
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,16666,111,0.38 [0.27-0.53],1.3170048647233754e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,16385,105,1.58 [1.14-2.21],0.0064006282342693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,16522,108,0.98 [0.56-1.70],0.9357480449058978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,16779,112,3.14 [2.46-4.02],5.2685281820886096e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,16562,112,2.86 [1.93-4.25],1.961725480384338e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,14046,96,1.18 [0.96-1.46],0.1105196078525499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,14003,91,0.98 [0.67-1.42],0.8953406904775718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,14464,98,1.45 [0.84-2.48],0.1782433083192705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,13971,93,1.05 [0.86-1.28],0.638554553134874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,14109,95,0.92 [0.55-1.56],0.7697408118682656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,16497,109,3.47 [2.42-4.98],1.6524427617347414e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,16562,112,2.18 [1.41-3.35],0.0004099592041064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,14466,98,1.32 [1.07-1.65],0.0113887628468298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,16536,110,0.98 [0.81-1.19],0.8567857763913566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,16222,104,0.96 [0.77-1.19],0.7051434386830175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,16279,105,0.98 [0.79-1.23],0.8858154339106638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,16279,105,1.12 [0.86-1.46],0.3941543480785094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,16643,113,2.35 [1.61-3.43],1.0456103936971691e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,16279,105,0.90 [0.67-1.22],0.50020334109465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,16497,109,1.33 [1.09-1.63],0.0054382003773599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,16739,109,1.40 [1.03-1.90],0.0294818949893617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,16279,105,1.14 [0.72-1.82],0.5710616137177233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,14046,96,1.22 [0.76-1.94],0.4104049765749873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,16279,105,0.84 [0.55-1.29],0.4242971395971954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,16388,112,1.67 [0.80-3.48],0.16969035486043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,14023,89,1.19 [0.60-2.39],0.6194496979692196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,16536,110,1.20 [0.72-2.00],0.4892848712427018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,16279,105,1.38 [0.85-2.26],0.1958613154907225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,16739,109,1.02 [0.68-1.52],0.9349971519066772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,16258,105,0.73 [0.46-1.15],0.1791473852948438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,16279,105,0.96 [0.75-1.21],0.7124916938588979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,16279,105,1.01 [0.61-1.68],0.957981453956736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,16279,105,1.03 [0.82-1.28],0.8267912712392916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,16588,110,1.62 [1.12-2.34],0.0107226121178203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,16334,108,1.43 [1.05-1.96],0.0254514318137978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,16517,113,1.18 [0.83-1.69],0.360103920139011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,16666,111,2.92 [1.89-4.49],1.1701999718494909e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,16739,109,2.32 [1.43-3.76],0.000686083679136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,16317,102,1.00 [0.90-1.11],0.9774787037704602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,16138,107,1.20 [0.96-1.49],0.1034114704983175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,16279,105,1.13 [0.89-1.44],0.3186254256967482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,16210,105,1.03 [0.76-1.39],0.8616307872095295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,16567,110,4.72 [2.62-8.50],2.2543944525525066e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,16545,112,3.25 [1.38-7.64],0.0069039928693118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,16588,110,0.66 [0.45-0.98],0.0372033072779189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,16740,111,1.89 [1.30-2.74],0.0008655276818171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,16279,105,1.18 [0.74-1.88],0.4812217306240549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,16554,112,1.49 [1.16-1.91],0.0018574299753142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,16279,105,0.61 [0.35-1.04],0.0701129504001356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,16279,105,1.13 [0.84-1.53],0.4170915185372083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,16279,105,0.71 [0.43-1.15],0.1596883296262076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,14046,96,0.70 [0.43-1.15],0.1568699054037223
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,14046,96,1.15 [0.87-1.53],0.3113333460068707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,14417,95,0.89 [0.66-1.19],0.4212386651405473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,16279,105,1.00 [0.68-1.47],0.9984887488656652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,16279,105,0.85 [0.58-1.25],0.4132609449138996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,13919,93,0.54 [0.31-0.95],0.0312621649105275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,16453,110,1.77 [1.21-2.60],0.0032931664090873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,16279,105,0.87 [0.53-1.42],0.5769410980962633
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,14417,95,0.92 [0.52-1.61],0.7667437987911405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,13971,93,0.83 [0.64-1.08],0.1721375370710887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,14046,96,1.15 [0.84-1.57],0.3887758755845724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,13983,94,0.93 [0.55-1.58],0.7989947041777768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,16536,110,1.84 [1.37-2.47],4.290703781338088e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,16279,105,0.75 [0.48-1.17],0.2059144894821755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,16163,102,1.07 [0.66-1.74],0.7847632258888723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,14046,96,1.06 [0.76-1.46],0.7405162626492241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,13984,96,1.16 [0.90-1.49],0.2435247787474291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,16279,105,1.26 [0.74-2.13],0.3954468315796633
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,16279,105,0.89 [0.76-1.05],0.1620785140348513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,16536,110,2.08 [1.40-3.09],0.0002665912430254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,16279,105,1.05 [0.93-1.18],0.4504392220204561
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,16536,110,1.22 [0.91-1.63],0.1896378157110163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,16497,109,1.25 [1.04-1.49],0.0158752956862205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,16508,108,1.18 [0.72-1.93],0.5234249587232958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,16562,112,3.82 [1.56-9.38],0.0033747221127122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,16536,110,0.97 [0.75-1.27],0.8405355155178661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,16588,110,1.10 [0.79-1.52],0.5710182462619513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,14209,95,1.26 [0.97-1.64],0.0831259753784268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16165,102,1.01 [0.74-1.37],0.9705348599273074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,14417,95,1.82 [1.37-2.42],4.167048410788474e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,16424,105,0.85 [0.63-1.14],0.2739596878976329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,14454,97,1.11 [0.78-1.57],0.5574579943734762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,14023,89,0.69 [0.32-1.46],0.3292568115146212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,16156,101,1.17 [0.83-1.64],0.3661372573096297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,14181,95,1.08 [0.75-1.57],0.667862334611287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,16588,110,1.64 [1.05-2.56],0.028293085130936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,16497,109,1.15 [0.84-1.57],0.3860924026595996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14109,95,1.03 [0.72-1.46],0.8735617740586181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",14444,95,0.81 [0.49-1.36],0.4267843903787344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16497,109,0.99 [0.83-1.18],0.9314626695639548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,14454,97,1.12 [0.87-1.43],0.3787322615336894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,14417,95,1.44 [1.10-1.88],0.0078421197461091
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,14404,96,1.10 [0.91-1.34],0.3227669030590495
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,14046,96,2.17 [0.70-6.74],0.1784042998780216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,16395,104,0.98 [0.81-1.19],0.8439086767894566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,16497,109,1.16 [0.85-1.57],0.3557699948065657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16271,105,1.05 [0.86-1.28],0.6204489723515775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,16279,105,0.96 [0.74-1.24],0.7498561707039948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,16536,110,1.06 [0.90-1.25],0.4828357983507853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,15965,97,0.86 [0.54-1.37],0.5240234838033142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,16536,110,1.31 [0.84-2.03],0.2320785393654803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,14479,98,0.69 [0.42-1.13],0.1396408565674344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,14289,96,1.06 [0.87-1.30],0.5599994207603938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,16536,110,0.87 [0.53-1.43],0.5912571539590785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,14181,95,0.72 [0.41-1.26],0.248219722332783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,16588,110,3.99 [2.18-7.31],7.180032729086301e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,16536,110,0.86 [0.61-1.22],0.4076804558549165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,14046,96,1.35 [0.84-2.16],0.2120995799983897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,16588,110,1.62 [0.98-2.69],0.0621406196969871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,16723,107,1.51 [0.53-4.31],0.4460384094125305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,14209,95,1.37 [1.05-1.80],0.0211185670322145
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,16594,110,2.14 [1.07-4.29],0.0310335349072915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,16222,104,0.60 [0.43-0.84],0.0026872186104791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,16271,105,1.02 [0.87-1.19],0.8072192374023974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,16489,108,2.89 [1.67-5.00],0.0001428820689478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,16637,112,1.14 [0.74-1.76],0.5507795053297571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,16279,105,1.30 [0.74-2.30],0.3638819117479704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,16723,107,1.48 [1.05-2.08],0.0270015320630971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,14479,98,3.53 [2.58-4.82],3.0056022887524032e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14494,98,0.51 [0.18-1.43],0.2000502925458517
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16666,111,1.33 [0.85-2.09],0.2093727082196101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14494,98,0.47 [0.20-1.06],0.0699973937133115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,14417,95,1.22 [0.83-1.78],0.3080691540554349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,16536,110,0.94 [0.71-1.23],0.6351828265901627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,14003,91,0.86 [0.64-1.18],0.3520448786204997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",14109,95,1.28 [1.02-1.62],0.0365967135049767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",14023,89,0.96 [0.60-1.55],0.8820319221517214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",16186,102,1.05 [0.75-1.47],0.7722090392543475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,13971,93,0.50 [0.28-0.89],0.0190338894108591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,16696,107,1.99 [1.13-3.54],0.0180406689581126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,14181,95,1.32 [0.92-1.90],0.1290448447315816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,16279,105,1.45 [1.11-1.91],0.0066861067800849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,13971,93,1.13 [0.83-1.55],0.4357852620420945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,14404,96,1.09 [0.87-1.37],0.4468838782880817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,16279,105,0.90 [0.61-1.34],0.6112244641198255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16497,109,1.43 [0.96-2.12],0.0764954192977718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,14404,96,1.00 [0.83-1.21],0.9898098823259768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,14023,89,1.08 [0.76-1.53],0.6680598121566432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,14096,95,1.27 [1.05-1.54],0.0145866294327559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,16186,102,0.88 [0.59-1.30],0.5183465936981297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,14192,96,1.80 [1.34-2.42],0.0001019641036964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,14046,96,0.74 [0.53-1.03],0.0735459225597112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,16637,112,0.47 [0.24-0.89],0.0215424792665942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,16186,102,1.39 [0.86-2.24],0.1851241185532904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,13971,93,0.83 [0.58-1.18],0.291920751390871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,14109,95,1.49 [1.09-2.04],0.0133045375578254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,14454,97,1.17 [0.65-2.13],0.601583123221713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,14209,95,0.95 [0.72-1.27],0.7487118394890961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,14209,95,0.74 [0.36-1.54],0.4251146818649338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,14417,95,1.42 [1.12-1.79],0.0031521226633514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,14003,91,1.39 [0.86-2.23],0.1785285850390274
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,14023,89,1.02 [0.78-1.33],0.8770116250585225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,14003,91,1.16 [0.98-1.37],0.0917664820665786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,16497,109,1.01 [0.82-1.24],0.9057201824589922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,14417,95,1.03 [0.83-1.28],0.7791329883155342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,16222,104,1.03 [0.83-1.27],0.8059133874071409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,14404,96,1.06 [0.95-1.18],0.3162863027944447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,16222,104,0.98 [0.85-1.12],0.7748012515700092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,13971,93,1.27 [1.09-1.47],0.0023458630573019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,14023,89,1.02 [0.71-1.46],0.9201703008507408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,16186,102,1.40 [0.97-2.03],0.0757027417590336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,16634,109,0.70 [0.40-1.24],0.222117034683913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,16562,112,0.53 [0.35-0.80],0.0028961949599105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,16186,102,0.85 [0.67-1.07],0.1680458066741263
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,14023,89,1.23 [0.76-1.97],0.3955075379258783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,14444,95,0.80 [0.51-1.26],0.3411701127641598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,16415,111,1.12 [0.99-1.26],0.0783838692962893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,16584,111,1.02 [0.68-1.54],0.9167793997209744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,16478,111,1.10 [0.66-1.82],0.7199563764637217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,16222,104,0.97 [0.86-1.10],0.6688343520758108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,16214,108,0.61 [0.42-0.88],0.0089660409243208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,16723,107,1.15 [0.80-1.66],0.4358147324776006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,14393,94,1.00 [0.68-1.45],0.9848453907962622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,14479,98,1.08 [0.89-1.31],0.45152050510244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,16723,107,1.28 [1.00-1.63],0.0504772796703246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,16608,112,0.89 [0.52-1.53],0.6776406504386556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,13824,93,0.55 [0.32-0.95],0.0331727653734805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,16041,109,0.98 [0.61-1.57],0.939379609280966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,14182,97,0.31 [0.15-0.66],0.0023969790016948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,16739,109,1.61 [1.06-2.44],0.0240978535087283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,14023,89,0.81 [0.54-1.22],0.3207353928928078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,16739,109,1.23 [0.86-1.76],0.2660494556059626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,14046,96,1.07 [0.71-1.63],0.735943811861781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,14454,97,1.54 [1.06-2.24],0.0246330475575171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",15664,100,1.40 [0.88-2.23],0.1578938480308158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",14003,91,0.71 [0.40-1.25],0.2334718492301809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",16497,109,1.51 [1.28-1.78],1.5905838244261286e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",16501,110,1.31 [1.04-1.65],0.0226366537821874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",16186,102,0.86 [0.60-1.22],0.3924983066239901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",14003,91,0.80 [0.44-1.47],0.4767034521529562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",14023,89,1.48 [1.30-1.67],1.564114473514331e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,16542,112,1.20 [0.90-1.60],0.207501056222076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,16739,109,1.48 [1.04-2.12],0.0294805166280879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,16637,112,1.77 [1.01-3.09],0.0466477369025118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14466,98,1.24 [1.00-1.53],0.0488407676651172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,14383,95,0.92 [0.60-1.42],0.7223137507109478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,16562,112,1.21 [0.94-1.55],0.1433382377766916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,16497,109,1.68 [1.16-2.45],0.0066998763538677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16564,113,1.69 [1.16-2.48],0.0069130763679441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16424,105,1.16 [0.97-1.38],0.0979486727187142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,14003,91,1.01 [0.68-1.49],0.9547699262080128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,16643,113,1.57 [0.97-2.54],0.0648757363542799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,14109,95,1.75 [0.91-3.36],0.0921754346374125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,14072,97,1.15 [0.60-2.20],0.6700015609452655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,16059,101,1.71 [0.70-4.18],0.2397815447667896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,16714,109,1.13 [0.82-1.56],0.4422855742917513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,14417,95,1.23 [0.79-1.92],0.35856642990468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,16279,105,1.41 [1.07-1.87],0.0163538408488138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,14417,95,1.05 [0.77-1.43],0.748527553799732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,16739,109,0.99 [0.79-1.24],0.9280386822854164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,16497,109,1.01 [0.88-1.15],0.9309269263258532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,14046,96,1.18 [0.94-1.49],0.1572662660701241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,16394,104,1.72 [1.11-2.66],0.0149837095322612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,16666,111,1.61 [1.22-2.13],0.000799856216809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,16696,107,1.08 [0.86-1.37],0.4974353428725405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,14485,98,0.50 [0.29-0.86],0.0121702321058836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,14444,95,1.23 [0.94-1.60],0.134071386676411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,16122,107,1.17 [0.77-1.78],0.4716116886110373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,14479,98,0.71 [0.46-1.09],0.1192512754339564
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,16621,109,0.81 [0.58-1.13],0.2110684061496469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,14444,95,1.03 [0.84-1.26],0.7712306124249511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,14466,98,1.33 [1.00-1.77],0.0523572318386214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,16693,107,1.54 [1.10-2.16],0.0124166767518832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,13722,94,0.84 [0.62-1.12],0.2364525283985983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,14023,89,1.01 [0.76-1.34],0.960001154326544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,14444,95,1.10 [0.65-1.88],0.7220694086021711
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,16562,112,1.09 [0.84-1.41],0.517190607925559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,16562,112,1.12 [0.66-1.89],0.6827333241971443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,14444,95,1.44 [1.05-1.97],0.0229343579331065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,16562,112,1.29 [0.80-2.06],0.2962373025623205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,16625,110,1.08 [0.61-1.89],0.8006981411041274
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,14494,98,2.05 [1.31-3.20],0.0016066040827508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,16564,113,1.67 [1.28-2.17],0.0001280254529089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,16535,105,0.81 [0.53-1.23],0.3197515634316427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,16696,107,1.01 [0.75-1.34],0.9724961304633996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,16579,112,2.41 [1.47-3.94],0.0004649260222538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,16643,113,1.06 [0.66-1.68],0.8129273702085318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,16222,104,1.23 [1.06-1.44],0.0080956975158379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16593,113,1.20 [0.91-1.57],0.1939590744225588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,16186,102,1.16 [0.85-1.58],0.3450379039878475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,16536,110,2.82 [1.50-5.31],0.0013116277312489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16588,110,1.24 [0.77-2.01],0.3765370081303337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,14479,98,1.00 [0.87-1.15],0.9471137555648284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,14003,91,0.98 [0.65-1.47],0.9297833420769548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16534,110,1.10 [0.65-1.87],0.7145835434429416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,14466,98,1.05 [0.81-1.36],0.7325232993497026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16779,112,2.27 [1.24-4.16],0.0077884691776277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16718,111,2.83 [1.68-4.77],9.65133529587084e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16279,105,1.09 [0.74-1.61],0.6548995217064653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16779,112,1.04 [0.82-1.33],0.7286881718981032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,14109,95,1.11 [0.82-1.52],0.4910204366959725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,14379,96,1.21 [0.92-1.59],0.1744317283996962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,14454,97,2.17 [1.21-3.88],0.0088594234834401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,14444,95,1.40 [0.87-2.28],0.1691304721666538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,14023,89,0.90 [0.62-1.28],0.5491482656338708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",14109,95,1.22 [0.97-1.52],0.0886086593041534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),14162,97,0.97 [0.87-1.08],0.601824427616129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,16497,109,1.23 [0.90-1.67],0.1926129169525489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,16562,112,0.76 [0.55-1.06],0.106243345802557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,15996,103,1.21 [0.90-1.60],0.2019258060351061
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,14003,91,0.94 [0.68-1.28],0.6750280345113862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,14003,91,1.08 [0.80-1.45],0.6174135391914894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,14096,95,1.28 [0.90-1.82],0.176049715741512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,14494,98,0.58 [0.28-1.20],0.1408413497962506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16665,107,1.25 [0.77-2.02],0.3716809083639335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,13994,96,0.51 [0.22-1.15],0.1049866728939979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,16497,109,1.51 [0.82-2.76],0.1862487303402796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,16562,112,1.26 [0.81-1.97],0.3033047778724521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,14096,95,1.14 [0.69-1.87],0.6056442951576291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,14096,95,0.95 [0.74-1.22],0.7137254943338447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16696,107,1.08 [0.82-1.43],0.59766861364216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,16497,109,1.54 [1.04-2.26],0.0293876009839345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,14404,96,1.52 [0.97-2.37],0.0692216961863567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,14096,95,0.60 [0.38-0.94],0.0274011513236514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,14466,98,1.25 [0.86-1.83],0.2373007424811224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,14417,95,1.14 [0.77-1.69],0.5202344053514669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,16279,105,1.17 [0.75-1.83],0.479259071083908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,14096,95,0.85 [0.50-1.43],0.5340151266189503
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,14444,95,1.00 [0.47-2.12],0.9951680597729676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,16222,104,0.84 [0.59-1.19],0.3274417230946641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,14209,95,1.16 [0.96-1.41],0.1342540210796149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,16536,110,1.15 [0.76-1.74],0.5218685801840615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,16536,110,1.48 [1.01-2.18],0.045312074643607
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,16723,107,1.08 [0.81-1.44],0.5934447590417951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,14417,95,1.40 [0.95-2.06],0.087240578940936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,16779,112,3.32 [2.10-5.26],2.931032404197075e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,16222,104,1.28 [0.96-1.70],0.0922572904097147
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,16508,112,2.62 [1.61-4.27],0.0001121771621048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,16279,105,0.69 [0.42-1.12],0.1347653266041883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,14417,95,1.34 [0.94-1.92],0.1068724738568306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,16354,104,0.99 [0.77-1.28],0.954096814585365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,16515,111,0.73 [0.46-1.14],0.1625776722916303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,16536,110,1.45 [0.93-2.28],0.1040247585190592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,16355,104,2.50 [1.41-4.44],0.0017792353804075
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,16424,105,1.40 [0.89-2.20],0.1449702139890812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,16222,104,0.81 [0.55-1.19],0.277009539276461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,16497,109,1.01 [0.83-1.24],0.922274112299498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,16186,102,1.00 [0.76-1.32],0.9956140332982898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,16495,112,1.07 [0.65-1.76],0.7902587068627129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,16222,104,1.39 [1.05-1.86],0.0234871565355915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,14023,89,0.91 [0.74-1.12],0.3812446107940808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,14096,95,1.02 [0.85-1.23],0.8242877237158424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14494,98,1.44 [0.55-3.80],0.4580727933364475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,13971,93,0.53 [0.28-1.00],0.05087426080044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,14181,95,1.09 [0.82-1.43],0.564346269358833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,14109,95,1.54 [1.06-2.23],0.022556426112235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16360,104,1.33 [1.02-1.73],0.036053200378204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,16222,104,0.76 [0.46-1.23],0.2583673473080285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,14096,95,1.01 [0.67-1.52],0.9762290877718244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,14209,95,0.90 [0.73-1.12],0.3443652267560395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,16222,104,1.04 [0.72-1.49],0.8459091353836158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,14466,98,1.47 [0.87-2.48],0.145549023737301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,14417,95,1.20 [0.86-1.68],0.2867298071418518
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14109,95,2.22 [1.01-4.89],0.0473743678311833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,14466,98,1.35 [0.97-1.87],0.0714278992107947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",13971,93,0.95 [0.64-1.42],0.8086214093501743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,16643,113,1.01 [0.88-1.16],0.8947255714907637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,16637,112,0.95 [0.52-1.75],0.8800424229409314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,14003,91,1.18 [0.90-1.55],0.2204903833118134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,14023,89,0.59 [0.31-1.14],0.1155860800127445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,14003,91,1.07 [0.82-1.40],0.604322327502356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,14454,97,1.25 [0.85-1.85],0.2599250850695357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,14404,96,1.13 [0.83-1.54],0.4237305440857487
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16536,110,0.97 [0.82-1.15],0.6974033455639759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,16222,104,0.92 [0.76-1.11],0.3797835587076309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,16394,104,0.98 [0.84-1.15],0.821555502298088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,13971,93,1.50 [1.07-2.10],0.0178995925300044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,16536,110,1.24 [0.83-1.85],0.3004226743320046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,14209,95,1.13 [0.86-1.47],0.3856947573164399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,13971,93,1.06 [0.94-1.20],0.3551299001247343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,16186,102,1.10 [0.78-1.54],0.5995471190132471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,16562,112,1.88 [0.99-3.58],0.0536766354849813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",14157,95,1.14 [0.90-1.44],0.275435470147831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,16394,104,1.35 [0.64-2.86],0.4291253644025709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,16592,113,1.82 [1.04-3.19],0.0373419736686228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,16395,104,0.89 [0.52-1.51],0.6614224434274499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,16222,104,0.95 [0.78-1.16],0.6311391694756152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,16186,102,0.99 [0.83-1.17],0.8884178872587503
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,16779,112,1.06 [0.78-1.44],0.7139778489605644
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,14292,98,0.94 [0.79-1.12],0.5071611479876224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,16666,111,1.30 [0.80-2.13],0.2892126902085422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",14444,95,1.31 [0.88-1.94],0.1829072518642374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,14046,96,1.02 [0.82-1.27],0.8704143792555511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,16475,111,1.39 [0.95-2.03],0.08969210258792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,14404,96,0.82 [0.38-1.75],0.6028648791272695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16424,105,1.29 [1.00-1.66],0.0500946776379986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",14404,97,1.76 [1.16-2.67],0.0078889580341072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,16595,112,1.24 [0.93-1.67],0.1410065214370153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,14096,95,1.07 [0.56-2.05],0.8337213914147739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",14109,95,1.18 [0.95-1.46],0.1341026079806681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,16222,104,0.96 [0.76-1.21],0.7257495188052033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,14003,91,0.93 [0.60-1.44],0.7529438967356477
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,16564,113,0.91 [0.59-1.40],0.6668137318099017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,14003,91,0.39 [0.18-0.85],0.0185626465002273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,16740,111,2.47 [1.04-5.86],0.0399578063227388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,14466,98,0.72 [0.38-1.39],0.3330545468058469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,14181,95,0.32 [0.18-0.58],0.0001947048605133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,14404,96,1.10 [0.84-1.44],0.4760219214760576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,16562,112,0.88 [0.77-1.01],0.071280837214461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,16564,113,0.72 [0.38-1.35],0.305342473708589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,16739,109,1.56 [0.81-3.00],0.1875054714731622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,16588,110,1.01 [0.88-1.16],0.9039910580475262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,16623,109,1.26 [0.54-2.91],0.5936273384210365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,16186,102,0.74 [0.39-1.38],0.3433627766145418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16536,110,1.13 [0.92-1.39],0.2296442649544945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,16693,107,1.09 [0.80-1.48],0.5814683015808183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,16271,105,1.00 [0.70-1.42],0.977996848504947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,14096,95,0.92 [0.66-1.27],0.6084732606431733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,14181,95,2.53 [1.41-4.55],0.0019669326338573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,16779,112,0.98 [0.65-1.47],0.9191881059204376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,16588,110,1.56 [1.08-2.25],0.0180727565484155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,16618,113,0.99 [0.81-1.19],0.8816916791778294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,16536,110,1.04 [0.91-1.20],0.546757162705958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,16637,112,1.04 [0.66-1.63],0.8644811106442709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,14096,95,0.95 [0.70-1.28],0.7226092669099669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16536,110,1.14 [0.99-1.32],0.0618215037041033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,16566,110,1.06 [0.83-1.37],0.6379361225182746
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,16279,105,1.27 [0.91-1.77],0.161641814949242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,14417,95,0.95 [0.79-1.14],0.5967650005653937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,14454,97,1.06 [0.85-1.30],0.6209279014129774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,16424,105,0.97 [0.81-1.16],0.7277077297334205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,14046,96,0.91 [0.53-1.58],0.7482841985569899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,13971,93,0.83 [0.59-1.17],0.2998103666127643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,16536,110,0.83 [0.69-1.00],0.0548560676516619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,16497,109,1.68 [1.39-2.02],4.708047274998001e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,15955,103,0.94 [0.77-1.14],0.5084106901186936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,16533,113,1.53 [1.19-1.97],0.0010452673445666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,16589,107,1.26 [0.93-1.71],0.1315089195690666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,16186,102,0.98 [0.57-1.69],0.9525087212027163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,14466,98,1.17 [0.83-1.63],0.3683874401159376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,16588,110,1.13 [0.81-1.57],0.4810520525724829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,16245,105,2.16 [1.51-3.10],2.65029171424838e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,16664,107,1.20 [0.96-1.51],0.116244525794508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,16560,110,1.18 [0.89-1.57],0.2413488990547541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",14003,91,1.38 [0.97-1.94],0.0707080607370025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,14096,95,0.84 [0.57-1.22],0.3556409957311851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,14209,95,0.91 [0.57-1.46],0.7063584112884327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,16533,112,1.09 [0.93-1.27],0.2792818921950853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,14181,95,1.32 [0.99-1.76],0.0630568801679952
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,16723,107,0.93 [0.56-1.54],0.7718193178415762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,14454,97,1.04 [0.51-2.13],0.9082364371458846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,14209,95,0.75 [0.42-1.33],0.3251261351487785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,13971,93,1.07 [0.64-1.78],0.8042540006198038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,13971,93,1.10 [0.87-1.40],0.403980618545859
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,16271,105,1.17 [0.94-1.46],0.1697525741526754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,16497,109,1.03 [0.84-1.26],0.7774271052442345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16618,113,0.94 [0.76-1.16],0.5405546948425216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,16588,110,1.12 [0.79-1.58],0.5362296790045262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,14382,95,1.49 [1.01-2.20],0.0425790132229556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,14485,98,2.64 [1.42-4.90],0.0021411508692651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,14096,95,1.00 [0.74-1.34],0.9740780109200756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",14003,91,0.54 [0.28-1.03],0.0607594558061189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",14444,95,1.12 [0.70-1.78],0.6405791471027003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",16186,102,1.23 [0.71-2.15],0.4589698873599077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",13941,93,0.62 [0.28-1.39],0.2493900132109294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",14444,95,1.17 [0.92-1.48],0.2058299796020647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",14046,96,0.98 [0.49-1.97],0.9536129468326084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,16467,109,1.03 [0.78-1.36],0.8470543147531637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,14096,95,1.14 [0.70-1.85],0.595399017181441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,16544,112,0.94 [0.75-1.18],0.5969595081142459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,16696,107,2.42 [1.70-3.45],1.0141449484927216e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,16637,112,1.01 [0.80-1.28],0.916946701640635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,14250,96,1.54 [0.99-2.38],0.0540916939351261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,16271,105,1.14 [0.82-1.58],0.4428511380711077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,14046,96,1.16 [0.94-1.43],0.1610927127474988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",14454,97,0.79 [0.35-1.79],0.5677938346108271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,14209,95,1.10 [0.92-1.31],0.3039917935461896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",14404,96,1.14 [0.91-1.42],0.2429285020693631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,16271,105,0.86 [0.49-1.53],0.6128396072518256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,14003,91,1.08 [0.81-1.44],0.5940973051526783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,14404,96,0.98 [0.82-1.17],0.8128445185824283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,14417,95,1.08 [0.89-1.32],0.4330081192954736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,14209,95,1.57 [1.20-2.04],0.0008947843600141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,16186,102,1.83 [1.37-2.44],3.642771292012631e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,16497,109,0.92 [0.85-1.00],0.0392186833655732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,14479,98,0.92 [0.75-1.14],0.4618309318301277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,13971,93,0.65 [0.36-1.19],0.1666115191176032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,16279,105,1.36 [1.12-1.66],0.0019120520287958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,14181,95,1.06 [0.56-1.99],0.8659568801073884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",14466,98,0.98 [0.74-1.29],0.8789036884718466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",14109,95,1.01 [0.81-1.28],0.9026389529764568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14444,95,1.21 [0.93-1.58],0.1599850466991788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,14466,98,1.12 [0.92-1.36],0.2781247798859473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,14003,91,0.65 [0.37-1.12],0.1224287223356361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,13971,93,0.69 [0.40-1.19],0.1793390364452817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,14479,98,1.06 [0.90-1.26],0.4989843657207921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",14003,91,0.94 [0.55-1.61],0.8247583383394781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,14109,95,1.06 [0.81-1.38],0.6957228284043471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,14109,95,0.96 [0.66-1.39],0.8243217080529657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,14096,95,1.18 [0.98-1.41],0.0777302303715538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",14096,95,1.01 [0.68-1.50],0.9585075411438408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,14444,95,1.04 [0.61-1.76],0.8984719826371999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,16279,105,0.88 [0.66-1.17],0.3835003363212257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,16588,110,1.12 [0.77-1.64],0.5538341687529407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,14023,89,1.32 [0.96-1.82],0.0832420068962352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,14003,91,1.09 [0.74-1.61],0.6595856861679609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,14181,95,0.95 [0.76-1.18],0.6309447833838953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,16617,113,1.14 [0.83-1.56],0.4253571860803815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,16222,104,0.97 [0.68-1.38],0.8541849139471082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,14003,91,1.25 [0.84-1.85],0.2705091374910552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,14096,95,1.04 [0.88-1.22],0.6578837663323882
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,16349,105,1.03 [0.77-1.38],0.85265708360756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,14417,95,1.15 [0.82-1.61],0.421910809865951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,16562,112,1.23 [0.94-1.60],0.128959277814172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,14012,94,0.81 [0.53-1.24],0.3352682262709164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,14082,95,1.13 [0.79-1.61],0.4970472381267409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14181,95,1.59 [0.64-3.97],0.3195431315476511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,16222,104,0.94 [0.67-1.31],0.7006367241586269
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,14374,96,1.11 [0.69-1.80],0.657815694566774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,14454,97,1.15 [0.66-2.02],0.6153277986768333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",14444,95,1.35 [0.88-2.05],0.1671822667436832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,16637,112,1.94 [1.08-3.47],0.0259626415491187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,16279,105,0.97 [0.69-1.36],0.8771654765410138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,16666,111,1.03 [0.59-1.77],0.9251930694863606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,16588,110,1.39 [0.75-2.57],0.2964011408170998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,16696,107,0.50 [0.32-0.76],0.0014142159545701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,16510,110,1.05 [0.87-1.27],0.6298539417410458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,16643,113,0.98 [0.84-1.15],0.8441815975742856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,16279,105,1.12 [0.82-1.54],0.466797133569232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,16510,109,1.32 [0.85-2.04],0.2175718740347433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14404,96,3.20 [2.01-5.09],9.206901635291e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,16723,107,1.23 [0.68-2.22],0.4862071837802263
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,16186,102,1.07 [0.84-1.38],0.5794131614125002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,14417,95,0.74 [0.50-1.10],0.136727934647706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,14028,96,1.04 [0.59-1.83],0.8852407041608488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,14404,96,1.00 [0.80-1.24],0.970665588229957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",16222,104,1.10 [0.90-1.35],0.3432479159002828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,14003,91,0.70 [0.38-1.31],0.2691404271670815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,14003,91,1.09 [0.82-1.45],0.5672267095154124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,14046,96,1.27 [0.73-2.23],0.3978634212715742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,16534,110,2.22 [1.36-3.64],0.0014964080176393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,16637,112,1.44 [0.89-2.32],0.1396265908786151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,14046,96,1.00 [0.67-1.50],0.9976611245826936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,14046,96,1.85 [1.27-2.72],0.0015168407856377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,16132,102,1.08 [0.74-1.58],0.6859119344096903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,14209,95,0.98 [0.75-1.29],0.9030034708047452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,16637,112,0.97 [0.66-1.44],0.8960713586657405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,16643,113,2.10 [1.23-3.60],0.0068506253660108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,14417,95,1.01 [0.86-1.20],0.8724388184090094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,14444,95,1.72 [0.86-3.46],0.1247619630754668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,14485,98,1.23 [0.94-1.61],0.1318852753730804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,16739,109,4.43 [2.64-7.42],1.5347275045354687e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,14046,96,1.05 [0.83-1.32],0.7051425419683977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16536,110,0.98 [0.82-1.16],0.7814564679802654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",16279,105,1.30 [1.00-1.69],0.0494404158379776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,14109,95,1.07 [0.82-1.40],0.6260913100562564
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,14444,95,1.37 [1.07-1.76],0.0113410299578227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,14003,91,1.01 [0.76-1.33],0.9678399570151572
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,14209,95,0.98 [0.68-1.43],0.934554372744228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,16222,104,1.13 [0.79-1.62],0.4877280435715128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",14404,96,1.15 [0.95-1.40],0.1462322335901695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,14003,91,1.06 [0.79-1.42],0.7143970850308481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,14003,91,1.06 [0.65-1.73],0.8183177291957862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,16424,105,3.25 [1.02-10.43],0.0470005386223691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,14466,98,0.99 [0.51-1.91],0.9802598613465072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,14454,97,1.16 [0.51-2.64],0.7272486930017112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,13817,92,1.49 [0.78-2.87],0.2286769300169362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,16604,109,1.54 [1.00-2.38],0.051242717943869
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,16588,110,1.14 [0.92-1.42],0.238464977832343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,16222,104,1.01 [0.72-1.41],0.9716922564030162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,14109,95,1.07 [0.70-1.64],0.759656420272036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,14413,97,1.34 [1.02-1.75],0.0348419151442945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,14096,95,1.07 [0.81-1.40],0.6467747196899452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,14023,89,1.07 [0.72-1.60],0.7304377422099309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,14046,96,0.69 [0.27-1.78],0.4467302169901365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,16592,113,1.61 [0.89-2.92],0.1163752191590158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,14367,95,1.09 [0.83-1.43],0.5493403828206007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16424,105,1.20 [0.99-1.45],0.0674772329731591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,13971,93,0.90 [0.52-1.56],0.7105575755851369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14444,95,1.14 [0.88-1.49],0.3238549943912786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,16588,110,2.80 [1.38-5.68],0.0043873604312635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,14003,91,1.14 [0.97-1.33],0.1068275019931926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",16186,102,1.42 [1.05-1.92],0.0224211302442352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",14003,91,1.14 [0.69-1.88],0.6164595497568441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",16186,102,1.35 [1.05-1.75],0.0203493925002029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,16779,112,3.30 [1.20-9.11],0.0210969506676248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,14479,98,1.47 [0.60-3.57],0.3985894003438976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,16779,112,2.28 [1.40-3.70],0.0008999468746159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,14232,96,2.11 [1.34-3.34],0.0013176240534596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,16562,112,1.49 [0.93-2.40],0.0964524363950987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,14046,96,0.71 [0.38-1.31],0.2737173509389803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,14046,96,0.98 [0.81-1.19],0.8584712384233398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,14466,98,1.35 [0.90-2.03],0.1474066854223239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,16271,105,1.04 [0.92-1.18],0.5248290434774735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,16536,110,1.05 [0.75-1.46],0.7779253216918255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,14003,91,0.52 [0.27-1.00],0.0490093106468556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,16222,104,0.96 [0.75-1.21],0.7058830513114649
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,16588,110,1.88 [1.29-2.75],0.0011113817015758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,14479,98,1.98 [1.10-3.57],0.0234862940599207
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,16562,112,1.25 [0.80-1.97],0.3302967779157449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,16723,107,1.09 [0.83-1.42],0.5391115561216191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,16562,112,2.36 [1.39-4.02],0.0014587001527175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,14485,98,1.11 [0.90-1.38],0.3340664382487889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,14444,95,0.84 [0.45-1.57],0.5785249275573774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,16689,111,3.45 [2.12-5.62],6.21624610189302e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,16588,110,1.93 [1.12-3.32],0.0175479854350019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,16279,105,1.14 [0.82-1.58],0.4284387083961476
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,14096,95,1.00 [0.57-1.74],0.9991793402348156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,16696,107,0.96 [0.74-1.25],0.7570764952824836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",14466,98,1.04 [0.80-1.37],0.7478166440666175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,14454,97,1.55 [0.97-2.46],0.0647010141885626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,16512,110,0.98 [0.81-1.20],0.8698228421101288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,16637,112,1.81 [1.42-2.31],1.4675903962415205e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,16536,110,1.04 [0.65-1.66],0.8805405082634878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,16222,104,0.82 [0.48-1.41],0.4820108188228862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,16562,112,1.12 [0.58-2.16],0.7279027148705468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,16696,107,0.64 [0.29-1.41],0.2703354225679281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,16562,112,1.10 [0.96-1.27],0.18573189499581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,16536,110,1.04 [0.84-1.27],0.7334869705082512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,14417,95,1.06 [0.87-1.28],0.5825503981784338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,16688,106,1.19 [0.75-1.91],0.4572835440592152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,16739,109,1.05 [0.80-1.39],0.7077899094941484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,14109,95,1.05 [0.48-2.28],0.90748827164317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,14003,91,0.60 [0.36-1.00],0.0512042859805889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,14375,96,1.25 [1.00-1.56],0.0470525319415069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16497,109,1.05 [0.78-1.41],0.7475225418559492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,16588,110,1.26 [0.91-1.75],0.1597532275025089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,14046,96,1.08 [0.85-1.38],0.520480375956917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,14003,91,0.62 [0.29-1.33],0.2192263257873379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,14003,91,0.87 [0.46-1.67],0.6844352109658656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,16186,102,1.01 [0.65-1.58],0.9515886126405496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,14046,96,0.74 [0.39-1.42],0.3696546080509184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,16375,104,0.84 [0.63-1.12],0.2374595741464773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,14444,95,2.14 [1.54-2.97],5.577036731858437e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,16163,102,0.94 [0.68-1.29],0.6864326385905553
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,14209,95,1.12 [0.84-1.47],0.4424901804039648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,14404,96,1.05 [0.79-1.39],0.7424307028532038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,16497,109,0.95 [0.55-1.63],0.8549712712236577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,16588,110,1.26 [0.86-1.85],0.2291015188896191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,14209,95,1.01 [0.74-1.38],0.954765924140912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,13629,92,1.20 [1.01-1.42],0.0374552390696693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,16408,110,1.41 [1.10-1.80],0.0067303153671679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,16643,113,1.26 [0.84-1.88],0.2714715503083109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,16497,109,0.95 [0.74-1.22],0.6910538855983663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,14023,89,1.06 [0.72-1.56],0.7696702406926069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,14454,97,1.01 [0.84-1.21],0.9401143711751394
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,14109,95,1.38 [1.05-1.83],0.0230094423155308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,16497,109,1.00 [0.69-1.44],0.983747191787348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,14439,98,0.39 [0.14-1.08],0.0709503961609977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,14454,97,1.07 [0.67-1.71],0.7755926793763176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,16592,113,1.64 [1.01-2.66],0.0446768461577666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,16470,109,1.12 [0.88-1.43],0.3561387731875344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,16689,111,1.77 [0.78-4.02],0.1699089361151139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,14096,95,0.98 [0.60-1.60],0.9332825715062156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,14023,89,1.00 [0.68-1.48],0.9830028889153428
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,14404,96,1.10 [0.79-1.54],0.5656229771856169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,14444,95,1.18 [0.86-1.61],0.305027158802642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",14109,95,1.00 [0.75-1.33],0.9818621766929988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,16696,107,1.09 [0.96-1.23],0.1757163433641758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,16503,112,1.15 [0.74-1.78],0.5324539391021625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,14003,91,1.05 [0.76-1.46],0.7648215334498771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,16279,105,0.99 [0.73-1.36],0.95910202790606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,16163,102,0.93 [0.73-1.18],0.5545080038981429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,16424,105,1.12 [0.95-1.33],0.1846852479082927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,14444,95,1.08 [0.92-1.26],0.3373513435445355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",14209,95,1.02 [0.69-1.52],0.9105439563838452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,16271,105,1.20 [0.89-1.62],0.2198564980889569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,14109,95,1.10 [0.70-1.73],0.6798236753095439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,13949,93,1.07 [0.73-1.56],0.7234052475159485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,16186,102,1.08 [0.82-1.43],0.575230412999173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,14046,96,1.01 [0.61-1.66],0.9833139258025764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,14319,96,1.11 [0.60-2.04],0.7445643199779973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,14454,97,2.24 [1.53-3.27],3.406124906396482e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,14003,91,1.14 [0.91-1.44],0.2581522189982989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,16695,111,2.60 [1.37-4.95],0.0036017692001051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,16588,110,0.71 [0.38-1.33],0.2819515867486716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,16279,105,1.11 [0.76-1.62],0.5752416513093153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,14209,95,0.91 [0.68-1.20],0.4911164585939866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,16588,110,1.12 [0.81-1.54],0.5118139034626992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,16536,110,1.18 [0.91-1.51],0.2082385412852156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,14181,95,1.46 [0.97-2.19],0.0708750743749815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,13971,93,1.06 [0.56-2.02],0.8485075425141603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,16186,102,1.00 [0.71-1.41],0.991660854264788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,14404,96,1.29 [0.70-2.38],0.4123733106380094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,14023,89,1.13 [0.92-1.38],0.2367568708597764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,14156,94,1.44 [0.99-2.10],0.0582449843272835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,14444,95,1.11 [0.84-1.46],0.4542775011528813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,16687,109,1.39 [0.65-2.96],0.3912337572880351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,14444,95,2.14 [1.02-4.50],0.043906918688944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,16562,112,2.73 [1.85-4.03],4.897060724255928e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,14404,96,1.24 [0.76-2.02],0.3928871948108358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,14404,96,1.79 [1.02-3.16],0.0431813197636261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,14417,95,1.80 [1.20-2.71],0.0045080054981656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,13971,93,0.95 [0.68-1.32],0.7451626273462437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,14417,95,0.97 [0.64-1.49],0.9019409655331012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,16779,112,0.77 [0.50-1.16],0.2116132410434404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,14404,96,1.14 [0.88-1.48],0.3194849591020421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,14466,98,1.11 [0.91-1.35],0.3206053357702529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,16694,107,1.33 [0.91-1.94],0.1413546178722039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,16497,109,1.16 [0.68-1.97],0.580214330235425
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,16696,107,1.00 [0.74-1.35],0.9993137837444664
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,16562,112,1.16 [0.88-1.52],0.2916542090995467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,13971,93,0.94 [0.63-1.41],0.7814966608916987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",13971,93,1.09 [0.77-1.54],0.6333784700994656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",14003,91,0.64 [0.40-1.03],0.068193000273492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",14181,95,1.03 [0.85-1.25],0.7591045479301846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,16779,112,1.02 [0.81-1.29],0.8380294362820706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,16643,113,0.99 [0.81-1.20],0.9007960621096048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,16222,104,0.71 [0.37-1.35],0.2965875850853907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,16562,112,2.84 [1.68-4.80],0.0001030650876262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,16779,112,1.42 [0.87-2.32],0.1589245237005082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,13971,93,0.50 [0.28-0.89],0.0188314966099374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,14181,95,1.51 [0.73-3.11],0.2690589405758672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,14479,98,1.19 [0.87-1.63],0.2829217036774502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,13971,93,1.12 [0.82-1.53],0.4822737090007073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,14444,95,1.01 [0.85-1.19],0.9081705097662492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,16643,113,0.97 [0.85-1.11],0.6349990041937676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",16222,104,0.77 [0.51-1.16],0.2030326752555804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,14096,95,0.92 [0.62-1.37],0.6757688145404717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,13971,93,1.24 [0.99-1.55],0.064591554224558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,14003,91,0.91 [0.63-1.31],0.6186959519098527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,14046,96,1.97 [1.42-2.74],5.3209649780267554e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,16779,112,0.96 [0.46-1.99],0.9058799436691471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,16588,110,1.11 [0.83-1.49],0.4899594543186998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,16588,110,1.12 [0.64-1.94],0.6927722959346683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,14109,95,1.54 [0.91-2.62],0.1108281376117294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,14181,95,0.90 [0.48-1.68],0.7322576993215345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,14485,98,0.72 [0.34-1.50],0.3759982749199942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,14046,96,0.91 [0.77-1.07],0.2728456622426984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,14390,97,1.07 [0.88-1.32],0.4856027081451353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,16186,102,0.90 [0.65-1.25],0.5272030326615564
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,13971,93,0.97 [0.66-1.44],0.8833930763207163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,14096,95,1.04 [0.77-1.39],0.8085803595752267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",16465,109,0.96 [0.77-1.20],0.7294899270339172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,14485,98,1.15 [0.90-1.46],0.2563006574559392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",14466,98,1.29 [0.91-1.84],0.1559144121688001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,16739,109,2.97 [1.81-4.87],1.6419713579694845e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,16718,111,1.46 [1.02-2.08],0.0384950211457336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,14315,97,0.59 [0.31-1.11],0.1033370151737685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,14003,91,0.98 [0.69-1.39],0.9076464881955236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,14096,95,1.15 [0.87-1.53],0.3170909986242897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,14046,96,0.87 [0.67-1.12],0.2709502769759883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,14444,95,1.04 [0.88-1.24],0.6327095664392819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,14404,96,1.18 [0.81-1.72],0.3865507374781146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,13971,93,0.97 [0.78-1.21],0.7944161363508475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,16424,105,1.28 [0.71-2.32],0.4066741727593953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,14181,95,1.41 [0.87-2.27],0.1624897790421725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,14485,98,0.66 [0.31-1.43],0.2943350817988357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,16379,107,1.00 [0.74-1.36],0.9913352857812834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",14444,95,1.16 [0.91-1.49],0.2345028782533033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,16374,108,2.98 [1.97-4.51],2.408677915828379e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16536,110,1.21 [0.93-1.58],0.1549814651593991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16588,110,2.21 [1.34-3.67],0.0020588504658225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,14046,96,1.01 [0.70-1.45],0.9656275659666383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,16588,110,1.62 [1.08-2.42],0.0188073655410192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,16562,112,1.24 [0.92-1.68],0.1627614031722701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,14181,95,0.88 [0.67-1.16],0.3559885946058555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,13949,93,1.09 [0.87-1.37],0.4636802738851947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,14466,98,3.40 [1.65-6.99],0.0008984383499681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,14003,91,1.11 [0.79-1.57],0.5483303193683386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,16601,113,1.13 [0.88-1.44],0.3456435732321237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,14209,95,1.06 [0.82-1.38],0.6398956004308638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,16424,105,1.07 [0.80-1.45],0.6344611176671979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,16637,112,3.65 [2.12-6.28],2.863193553088825e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,16759,112,0.89 [0.62-1.29],0.5450520807890402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",16546,110,1.21 [0.92-1.60],0.1688660907592291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,16643,113,1.05 [0.87-1.27],0.6115135158699216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,16588,110,0.83 [0.51-1.35],0.4469512635252159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,16740,111,1.33 [0.96-1.85],0.0876392858545275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,16588,110,1.90 [1.40-2.57],3.268450694478849e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,16472,112,2.87 [1.67-4.93],0.000133455644924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",14454,97,0.75 [0.54-1.03],0.0780999465891901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",14046,96,0.89 [0.53-1.48],0.645271589095173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",14454,97,1.10 [0.90-1.35],0.3570371754330654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,14454,97,1.05 [0.80-1.40],0.7159381127413094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,14138,97,0.66 [0.27-1.66],0.3790010591582132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,16186,102,1.23 [0.78-1.95],0.370889087921772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,16562,112,1.32 [0.90-1.92],0.1574637200488103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,16562,112,1.16 [0.91-1.49],0.2337454956289966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,14426,96,1.15 [0.82-1.61],0.4311571285549577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,16727,111,1.12 [0.70-1.77],0.6387679568282698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,16222,104,0.64 [0.34-1.23],0.1815062600718228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,14454,97,1.21 [0.64-2.30],0.5647671429629679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,16536,110,0.95 [0.77-1.17],0.6283501144124379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,16710,110,4.25 [2.41-7.51],5.755793067955339e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,16515,112,1.07 [0.75-1.53],0.7021020273843093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16473,110,0.98 [0.90-1.08],0.7059072983299592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,14003,91,0.92 [0.70-1.21],0.5735863558873883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,14003,91,1.13 [0.80-1.58],0.4823462843741941
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,14096,95,1.40 [1.04-1.88],0.0274859392282333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,16157,102,0.99 [0.84-1.16],0.8647964439259098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,14485,98,1.27 [0.95-1.69],0.1028858242147671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,14454,97,1.13 [0.89-1.44],0.3068908515224747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,16564,113,1.04 [0.98-1.10],0.2169466577575885
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,14109,95,1.05 [0.74-1.50],0.7784960487349232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,14023,89,0.89 [0.55-1.43],0.6230476172804204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",16279,105,1.03 [0.89-1.19],0.6792950579383628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,16497,109,1.37 [0.45-4.12],0.5777490268488736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,16637,112,0.88 [0.48-1.59],0.6659841963711153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,14046,96,1.68 [1.24-2.28],0.000898453280768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,14046,96,0.55 [0.27-1.16],0.1151698848597684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16497,109,1.48 [1.00-2.18],0.0474370033910352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,14109,95,0.79 [0.60-1.05],0.1110754716535846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,14485,98,0.61 [0.33-1.13],0.1189129926547423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,16271,105,1.45 [0.89-2.35],0.1352943079083804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,16643,113,0.66 [0.43-1.01],0.056817809547898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,14479,98,1.13 [0.68-1.88],0.6284782057546919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,14394,98,1.05 [0.84-1.33],0.6610065919463404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,16696,107,1.04 [0.72-1.50],0.8463648546119795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,16610,110,1.04 [0.87-1.25],0.6520407502697236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,14209,95,1.01 [0.74-1.37],0.944926580938599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",14479,98,1.10 [0.83-1.45],0.5181154160622443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,14046,96,1.00 [0.54-1.82],0.9877704283003724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,16222,104,1.01 [0.58-1.74],0.9783411485817552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,14046,96,0.88 [0.60-1.28],0.4979691067979189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,14466,98,1.11 [0.76-1.60],0.5901599032457725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,16497,109,0.99 [0.75-1.31],0.9562027024368588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,14417,95,1.03 [0.81-1.31],0.8172960490934278
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16637,112,1.02 [0.85-1.21],0.8569197983716836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,14209,95,1.22 [0.98-1.52],0.0768363339904908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,14444,95,1.14 [0.91-1.44],0.2646449651263083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,14444,95,1.33 [0.87-2.04],0.1948615698656056
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,16562,112,1.12 [0.90-1.38],0.3093604690418853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,16739,109,0.96 [0.80-1.15],0.6737435869362782
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,14404,96,1.06 [0.90-1.25],0.4498135198561214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,16424,105,1.16 [0.76-1.77],0.5056672322972431
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,14096,95,0.91 [0.67-1.22],0.5076184253640934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,16572,112,0.99 [0.84-1.16],0.8812907632656538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,16222,104,1.25 [0.98-1.59],0.0767138449616526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,13971,93,0.88 [0.40-1.96],0.7623905517704683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,14479,98,1.48 [0.90-2.44],0.1230084006452924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,14417,95,1.21 [0.87-1.67],0.2574675343595907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,16693,111,2.54 [1.81-3.55],5.488889494053033e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,16086,101,0.93 [0.75-1.14],0.4718757306996212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,14226,96,1.02 [0.75-1.39],0.8809748159605801
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",16279,105,1.13 [0.89-1.43],0.3301400394087284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",16739,109,1.01 [0.78-1.30],0.9578410375391976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,16723,107,1.04 [0.79-1.36],0.8045586153747278
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,16279,105,1.36 [0.78-2.37],0.2781772596711163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,16564,113,0.72 [0.36-1.44],0.3557300689440843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,14479,98,0.84 [0.58-1.23],0.3649596701483736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,14479,98,0.71 [0.48-1.05],0.0858155298619918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,16279,105,1.20 [0.88-1.64],0.2573317539628705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,14096,95,0.94 [0.50-1.76],0.8461950269417505
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16562,112,1.03 [0.84-1.26],0.7586671282920471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,14424,97,1.16 [0.91-1.48],0.2341878945824686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,16279,105,1.01 [0.68-1.51],0.9585879379142404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,14003,91,0.87 [0.53-1.44],0.5949971695326588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,14181,95,1.04 [0.89-1.22],0.6437236432400784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16222,104,1.13 [0.88-1.45],0.3533776456196615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,16696,107,1.00 [0.80-1.26],0.9784820449454504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,14454,97,1.43 [1.01-2.03],0.0436274068078006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,16634,109,0.39 [0.24-0.63],0.0001559374575175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,14003,91,0.42 [0.19-0.91],0.0273688855496314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,16536,110,1.15 [0.85-1.56],0.3550993691409011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,14494,98,0.63 [0.30-1.32],0.222402983418727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,14071,95,1.03 [0.78-1.37],0.8191899428623357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,14046,96,1.06 [0.70-1.60],0.776994296751193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,14109,95,1.47 [0.89-2.43],0.12890113622572
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,16666,111,1.45 [1.11-1.89],0.0058477952774087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,14046,96,1.64 [1.17-2.29],0.0038170878248365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,16524,111,1.25 [0.82-1.90],0.2951044169783821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,14454,97,0.81 [0.48-1.37],0.4367850126937873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,16526,112,1.71 [1.17-2.52],0.0060435016484614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,16186,102,0.97 [0.82-1.13],0.6590773566141725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,16723,107,3.03 [1.58-5.79],0.000839400952597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,16155,106,1.04 [0.73-1.48],0.815799876165622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,14209,95,1.28 [0.72-2.27],0.398302417175042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,14341,97,1.75 [0.98-3.11],0.0574048346507628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,14404,96,0.70 [0.48-1.05],0.0826344022026487
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,14404,96,1.03 [0.95-1.11],0.487893365407934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,16424,105,1.01 [0.87-1.17],0.8736832776859802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,16536,110,1.16 [0.92-1.46],0.2153694466927676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,16222,104,1.31 [0.94-1.84],0.109684282662483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,13971,93,0.94 [0.49-1.81],0.8591655911003423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,14444,95,1.19 [0.82-1.73],0.3481455484879937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,14096,95,0.94 [0.64-1.38],0.756193676220354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,16497,109,1.02 [0.75-1.38],0.9193703491867276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,16391,105,1.30 [0.82-2.05],0.2654696903978699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,16346,102,1.28 [0.79-2.06],0.310467285908681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,16536,110,1.25 [0.91-1.72],0.1686297342116222
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,14046,96,1.11 [0.80-1.54],0.5304618662502902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,16536,110,1.01 [0.85-1.21],0.886791516266269
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,16222,104,1.06 [0.80-1.40],0.698065764168267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13705,90,1.05 [0.86-1.27],0.6442151686010854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",16186,102,0.66 [0.37-1.19],0.1694335972309713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,16476,108,2.18 [1.42-3.36],0.0003880689470411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,13936,94,1.24 [0.87-1.78],0.23259873815488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,14466,98,1.21 [0.97-1.50],0.0935179935975383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,14096,95,0.88 [0.69-1.13],0.3158991849142971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16536,110,1.06 [0.70-1.62],0.7864736690789131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,16186,102,1.87 [1.22-2.88],0.0042964301639471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,16271,105,1.13 [0.80-1.60],0.4767667308950613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,14046,96,1.21 [0.87-1.68],0.2562164939434655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16424,105,0.93 [0.75-1.17],0.5616877899808654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16618,113,1.03 [0.85-1.24],0.7666207057635287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,14025,96,0.75 [0.41-1.34],0.3287530951361835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,14466,98,1.49 [0.78-2.86],0.2312384792436882
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,14479,98,2.56 [1.18-5.58],0.017921311415279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,16779,112,0.67 [0.38-1.19],0.1766415882521073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,14404,96,1.46 [0.99-2.16],0.054427091003893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,14404,96,2.27 [1.15-4.47],0.0176905749510482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,16513,110,1.64 [0.82-3.27],0.159689348899493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16373,104,1.27 [0.76-2.11],0.3660939459556295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,14454,97,1.12 [0.67-1.86],0.6625693753760229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,16779,112,0.93 [0.48-1.82],0.8377434439403261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,14466,98,1.28 [0.70-2.32],0.4273346888107481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,14181,95,1.16 [0.83-1.61],0.3935059745497538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,16111,102,1.48 [1.13-1.94],0.0042304159681238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,14209,95,1.11 [0.72-1.72],0.6389445258342832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,16536,110,1.30 [0.89-1.89],0.1826531462354509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,16629,106,1.07 [0.91-1.25],0.3940350406633961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,16696,107,1.73 [1.13-2.65],0.0121832901333463
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,14417,95,1.05 [0.75-1.47],0.7740124561369256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,16186,102,1.08 [0.78-1.51],0.6352588428728768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,14109,95,1.14 [0.72-1.80],0.5786956800788765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,14003,91,1.13 [0.94-1.37],0.1866560539314861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,14494,98,0.74 [0.49-1.13],0.159497460263366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,16488,111,1.51 [1.03-2.22],0.0362812888688538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,16632,110,2.33 [1.30-4.18],0.0044276213577129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,14210,96,1.43 [1.07-1.92],0.0165407805642385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,14466,98,1.19 [0.84-1.70],0.3320810945561675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,14466,98,1.05 [0.88-1.26],0.5993523355640025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,14466,98,1.08 [0.85-1.37],0.5444714133307795
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,14417,95,1.05 [0.75-1.45],0.7845237657707927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,14003,91,1.13 [0.84-1.52],0.4200923725550062
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,16279,105,1.05 [0.85-1.28],0.6718132017203596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,14003,91,0.96 [0.76-1.22],0.7648879491936296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,14023,89,0.86 [0.57-1.29],0.4661908433035032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,14417,95,1.27 [0.90-1.78],0.1706040313956429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,16536,110,0.85 [0.58-1.23],0.3844466210723528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,16186,102,1.07 [0.76-1.51],0.6968365505550126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,14181,95,1.08 [0.84-1.40],0.5327917549690901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,16222,104,1.05 [0.78-1.40],0.7611963124404767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,16279,105,1.04 [0.78-1.39],0.7862863451208042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,14096,95,1.04 [0.79-1.37],0.7686069914867206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,16222,104,0.97 [0.66-1.42],0.8601029454957291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,14209,95,0.70 [0.44-1.12],0.139033619770326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,14046,96,0.92 [0.48-1.79],0.8135531660585301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,14417,95,1.26 [0.89-1.78],0.1866465083282378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,14109,95,1.08 [0.75-1.56],0.694575358872226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,14023,89,0.77 [0.40-1.48],0.4332791883634004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,16222,104,0.91 [0.61-1.37],0.6634916042191946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,14046,96,1.08 [0.84-1.39],0.5506037775164566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,14209,95,1.08 [0.75-1.57],0.6692736554530132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,16222,104,1.03 [0.62-1.71],0.907962959269848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,16689,111,1.06 [0.75-1.51],0.7351912849095711
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,16186,102,1.21 [0.75-1.97],0.4350527698272088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,13971,93,1.04 [0.66-1.64],0.8717886183971146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,16222,104,1.05 [0.79-1.41],0.7229401994745484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,14444,95,1.68 [1.14-2.47],0.0085380805685088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,16160,102,1.45 [1.03-2.03],0.0309200294507474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,14444,95,1.05 [0.82-1.36],0.6839274146872728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,14003,91,1.23 [0.84-1.79],0.2809037830540948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,13971,93,0.91 [0.58-1.42],0.6773121744499847
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,14096,95,1.21 [0.96-1.51],0.0997611070912841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,16497,109,1.08 [0.87-1.34],0.477544018030177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,16497,109,1.29 [0.97-1.73],0.0812389945918318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,14404,96,1.10 [0.81-1.49],0.5581319941867032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,14046,96,1.34 [1.08-1.65],0.0075776129219502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,14109,95,1.02 [0.84-1.25],0.808810625173273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,14417,95,1.23 [0.89-1.69],0.2165994529296585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,16271,105,1.40 [1.05-1.87],0.0229806123247231
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,14109,95,1.06 [0.41-2.77],0.9033415909553384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,14444,95,0.92 [0.66-1.28],0.6135991413243342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,16485,108,1.04 [0.74-1.45],0.8226756529795527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,16779,112,1.04 [0.78-1.38],0.8116738223214697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,16779,112,1.15 [0.90-1.48],0.2571299112370603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,14417,95,1.13 [0.70-1.82],0.6123006464563829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,16592,113,1.30 [0.96-1.77],0.0907623689610722
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,14046,96,1.19 [0.83-1.69],0.3479368707977435
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,16588,110,2.05 [1.23-3.40],0.0057312908167788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REN,Renin,16562,112,1.19 [0.99-1.42],0.0569038806897339
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,14046,96,0.85 [0.50-1.44],0.5451448798047851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,13971,93,0.99 [0.56-1.74],0.9619170591043584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16497,109,0.99 [0.64-1.52],0.95366869446661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,16550,109,1.35 [0.93-1.96],0.1143956133263715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",14003,91,0.98 [0.65-1.47],0.9244751107400812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,14417,95,1.54 [0.63-3.74],0.3421995015670289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,14444,95,1.10 [0.85-1.42],0.4860548463204049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,14209,95,1.15 [0.88-1.50],0.2992281492956178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,16696,107,1.34 [0.79-2.27],0.2802493774428305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,16696,107,1.42 [0.78-2.58],0.2525481941403243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,14444,95,1.00 [0.71-1.39],0.9784829972367232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,16279,105,0.90 [0.67-1.20],0.4656279795561526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,16323,104,0.97 [0.84-1.13],0.7115732885884924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,14046,96,1.03 [0.69-1.53],0.8869301840562112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,14181,95,1.46 [1.02-2.09],0.0389584472119571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,16665,107,1.08 [0.81-1.44],0.5879809770878628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,14466,98,1.05 [0.86-1.28],0.6228192254257341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,14003,91,0.90 [0.65-1.24],0.5189299157070678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,14444,95,0.87 [0.53-1.42],0.572218563061014
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,14152,94,1.04 [0.70-1.55],0.8300894714473577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,14485,98,0.99 [0.48-2.07],0.9864405504024886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,14109,95,1.02 [0.68-1.53],0.9324473916850972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,16495,111,1.05 [0.91-1.21],0.4963320703656785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,14000,97,1.46 [0.74-2.85],0.2738249135617678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,14376,97,1.60 [1.15-2.23],0.0048133536599857
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,14444,95,1.17 [0.81-1.69],0.3989341524766403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,16714,112,2.30 [1.42-3.73],0.0007122081034807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,14109,95,2.04 [1.31-3.19],0.0016503630212556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,14046,96,0.78 [0.45-1.36],0.379897135280379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,14046,96,0.68 [0.36-1.31],0.2515777844722665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,14209,95,1.09 [0.83-1.43],0.5205408467426289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,16222,104,1.00 [0.76-1.30],0.9715656278568704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,14209,95,1.21 [0.92-1.60],0.1774156049656541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,14109,95,1.04 [0.79-1.36],0.80578059619137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,16592,113,3.78 [2.37-6.02],2.255053787920382e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,16696,107,2.33 [1.16-4.66],0.0169544451169655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,14109,95,1.81 [0.60-5.46],0.2912388166823881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16562,112,1.37 [0.81-2.29],0.2360645867899318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,16497,109,0.99 [0.66-1.48],0.9467436509221764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,14046,96,0.90 [0.46-1.75],0.7592965179297683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,14209,95,1.23 [0.96-1.57],0.1067212180938628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,14096,95,0.89 [0.53-1.48],0.6508146449761851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,14109,95,1.03 [0.62-1.71],0.9032861354405546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,14003,91,0.61 [0.34-1.11],0.1063714988887835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,14096,95,1.03 [0.88-1.20],0.7027861711829786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,16222,104,1.10 [0.79-1.53],0.562397272840474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,16222,104,1.13 [0.87-1.46],0.3674053617994819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,14023,89,1.09 [0.88-1.36],0.4084644884310622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,16424,105,1.00 [0.59-1.68],0.9909282337742678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,16723,107,1.18 [0.65-2.15],0.5769267937203812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,16497,109,1.62 [0.92-2.87],0.0967365173273778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,14003,91,0.71 [0.43-1.17],0.1822598312003376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",14444,95,1.09 [0.88-1.35],0.430530092986189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,16723,107,1.77 [1.13-2.79],0.0131394636393866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,16222,104,1.11 [0.96-1.29],0.1756353982450819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,16696,107,1.03 [0.79-1.35],0.822742861509326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,14003,91,0.64 [0.32-1.29],0.2144913644920126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,16446,111,1.45 [1.11-1.89],0.005684275514732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,16349,109,0.96 [0.76-1.21],0.7113084831882989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,14046,96,1.10 [0.63-1.90],0.7435801470426473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,14444,95,1.20 [0.85-1.69],0.3090754751057094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,16163,102,1.03 [0.78-1.38],0.8150727909819949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,14417,95,0.90 [0.56-1.46],0.6796401368594904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,16637,112,0.96 [0.72-1.29],0.7988058553863053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,14444,95,1.02 [0.68-1.52],0.9400679423987984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,16271,105,1.16 [0.87-1.55],0.3061146004210429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,14494,98,0.45 [0.13-1.53],0.2014223808764582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,14444,95,1.24 [0.65-2.37],0.5043968589354086
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,14023,89,0.96 [0.64-1.44],0.842708242136311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,16536,110,1.01 [0.80-1.28],0.9373291267451814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,14209,95,0.89 [0.67-1.19],0.4376336179808362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,14409,98,1.05 [0.88-1.26],0.5782053822271879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,14003,91,1.13 [0.69-1.87],0.6242480221597542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,14003,91,0.58 [0.34-0.99],0.0475755072013387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,14209,95,0.93 [0.68-1.27],0.6564055635732544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,14444,95,0.99 [0.50-1.94],0.9682392412680436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,14449,98,0.85 [0.49-1.48],0.5687207529856715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,16497,109,1.01 [0.83-1.24],0.8984270923355957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,16696,107,1.26 [0.73-2.19],0.4062867967298018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,16186,102,0.81 [0.56-1.17],0.2680590646319576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,16116,102,1.84 [1.14-2.98],0.0127308318205622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,16779,112,1.36 [0.92-2.01],0.1224415276197308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,16696,107,3.01 [1.79-5.04],2.9208888638325467e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,16630,106,1.90 [1.16-3.12],0.0106823379290304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,16592,113,1.24 [0.76-2.01],0.3959156981832893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,16584,113,0.85 [0.64-1.14],0.2760402289929793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,14003,91,0.89 [0.44-1.79],0.7417110276459025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,14181,95,1.09 [0.51-2.32],0.8246891241493967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,16618,113,1.05 [0.88-1.25],0.6001788426878651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,16279,105,1.64 [1.15-2.34],0.0066420571417419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,14023,89,1.01 [0.76-1.34],0.9430268809265214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,16665,107,1.77 [1.27-2.46],0.000714039939647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,14023,89,1.01 [0.66-1.53],0.9663526936256398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,14096,95,1.01 [0.50-2.04],0.9674629205884194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,14096,95,0.99 [0.57-1.73],0.9683049488162856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,14023,89,1.07 [0.73-1.59],0.7198988821271626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,14109,95,1.19 [0.76-1.88],0.443743688261316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,16222,104,1.20 [0.99-1.46],0.0642545614026051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,14055,95,1.32 [0.89-1.95],0.1612640733654043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,14466,98,1.10 [0.56-2.19],0.7765871550128414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,14109,95,1.19 [0.99-1.43],0.0651853543115593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,16536,110,1.07 [0.79-1.45],0.6789945956641579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,14096,95,0.79 [0.52-1.19],0.2612129331206237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,16562,112,2.33 [1.66-3.28],1.072352187539008e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,16562,112,0.67 [0.47-0.95],0.0263463846502483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,14417,95,1.01 [0.85-1.20],0.9391292650345476
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,14404,96,1.46 [1.17-1.81],0.0006351249719482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,14181,95,1.48 [0.95-2.32],0.086472256492737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,14109,95,1.04 [0.80-1.35],0.7582937883975899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,14109,95,1.63 [1.07-2.49],0.0229069646057556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,16779,112,1.93 [1.39-2.67],8.093401141213523e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,14494,98,0.50 [0.21-1.17],0.1099390047115045
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,14494,98,0.55 [0.24-1.27],0.161035623771104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,16666,111,1.22 [0.91-1.63],0.1877367051032131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,16536,110,1.84 [0.94-3.59],0.074811249293242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,16562,112,1.52 [0.81-2.84],0.1901464348533545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,14181,95,1.29 [0.85-1.98],0.2320123300567343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,16497,109,1.37 [0.85-2.22],0.1960520856532974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,16696,107,0.71 [0.40-1.26],0.2452198124212922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,14046,96,1.43 [0.74-2.79],0.2893821317693112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,16740,111,3.35 [2.34-4.81],5.099129279959346e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,14444,95,1.07 [0.83-1.38],0.5777576921101871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,14209,95,1.11 [0.81-1.52],0.5125989191974296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,14429,97,1.75 [1.06-2.89],0.0274995491184064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,16497,109,1.60 [0.97-2.64],0.0671804879539997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,14197,96,0.30 [0.02-3.83],0.3550613195356217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,16779,112,1.12 [0.74-1.68],0.5872864476584009
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,16071,108,1.13 [0.98-1.30],0.1043661496335625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,14436,98,0.56 [0.15-2.13],0.3978211168233864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,14214,97,1.01 [0.44-2.29],0.9860748458544588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,14265,97,0.76 [0.38-1.49],0.4191773294859329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,14494,98,0.98 [0.28-3.39],0.9749233110678942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,14494,98,1.75 [0.63-4.87],0.2800962101270202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,16410,109,1.48 [1.19-1.84],0.0004483222422393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,16538,110,1.01 [0.84-1.22],0.8888543399399157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,16271,105,0.65 [0.49-0.86],0.0027491341625446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,16639,106,1.05 [0.78-1.42],0.739825274463654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,16739,109,1.09 [0.83-1.42],0.5384755098194105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,16424,105,1.11 [0.65-1.88],0.7072364723962703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,14467,98,0.36 [0.14-0.92],0.0336965346883919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,14467,98,0.55 [0.28-1.10],0.0914147511891945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,16779,112,1.09 [0.84-1.40],0.52354639067463
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,14466,98,0.96 [0.71-1.30],0.8041951036201858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,14262,97,0.70 [0.33-1.47],0.3438248320567881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,14201,94,0.36 [0.13-1.04],0.0584524427086159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,14467,98,0.48 [0.22-1.04],0.0641224554594063
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,14209,95,1.15 [0.99-1.34],0.0742798086703147
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,14157,95,1.04 [0.54-2.01],0.8972395681735272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,14404,96,1.29 [0.92-1.80],0.1341469530818738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,16186,102,1.03 [0.79-1.36],0.8227599097513671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,16371,104,1.23 [0.69-2.18],0.4854106713338917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,14096,95,1.69 [1.00-2.88],0.0520885766348368
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,16637,112,1.28 [0.70-2.34],0.4139325632907864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,16497,109,3.08 [1.89-5.04],6.960374609012377e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,16497,109,0.96 [0.76-1.21],0.7346767881669722
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,16374,104,1.17 [0.79-1.74],0.4248449323498523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,14181,95,0.83 [0.50-1.37],0.4677782229327318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,16222,104,1.09 [0.82-1.45],0.5468992280627272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,16222,104,0.87 [0.62-1.23],0.4288219634436678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,16562,112,1.08 [0.85-1.38],0.5314844879288403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,14202,97,1.50 [1.11-2.03],0.0082469944702293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,16222,104,0.98 [0.82-1.17],0.8290553339451813
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,16536,110,0.89 [0.65-1.22],0.4677322003870835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,14023,89,1.03 [0.75-1.43],0.8384197963641384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,14404,96,1.23 [0.88-1.73],0.2236347209207447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,14137,95,1.20 [0.95-1.52],0.1213902930876391
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,14454,97,1.07 [0.80-1.42],0.6421130925201599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,14485,98,1.25 [0.84-1.85],0.2755979186595876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,13971,93,1.11 [0.95-1.30],0.1814330352771845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,13969,89,1.04 [0.84-1.29],0.7025504493519632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,14046,96,0.79 [0.48-1.28],0.329515969406308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,14479,98,2.14 [1.23-3.74],0.0074218003645833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",16618,113,1.19 [0.98-1.46],0.0789648317157865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,14209,95,0.86 [0.51-1.45],0.571418397236936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,16615,112,1.45 [1.02-2.07],0.0408752927947088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,16643,113,1.73 [1.19-2.53],0.0043705897753929
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16536,110,2.31 [1.47-3.63],0.0002842151181251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,16186,102,1.12 [0.91-1.38],0.294972769997347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,16588,110,1.21 [1.01-1.45],0.0337348256362681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,16723,107,1.83 [1.11-3.02],0.0182389992281219
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,16562,112,2.51 [1.45-4.32],0.0009686675201008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,14109,95,1.64 [1.07-2.51],0.0237890732279336
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,16695,107,1.36 [0.76-2.42],0.296190190307864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,14109,95,1.02 [0.55-1.89],0.9532793486103378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16629,109,1.27 [0.93-1.75],0.1382538155513827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,16547,113,1.60 [1.13-2.25],0.0075394279954945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,14046,96,0.74 [0.52-1.05],0.0948529786874992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,16497,109,0.97 [0.80-1.18],0.7728666278452155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",16186,102,0.89 [0.63-1.25],0.4963697326785184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,16279,105,1.20 [0.89-1.63],0.2293768161793626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,16394,104,1.06 [0.84-1.34],0.6317616537681006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,16643,113,0.98 [0.84-1.16],0.8416285862069016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,14003,91,1.05 [0.64-1.75],0.8367678065608111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,14444,95,1.05 [0.87-1.27],0.6165092618177166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,16279,105,1.13 [0.84-1.51],0.4330008572424464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,16222,104,1.35 [0.85-2.15],0.1979933328178489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,16536,110,1.37 [1.03-1.81],0.0283146473833329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,16222,104,1.71 [1.23-2.38],0.0013321915192554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,14003,91,0.52 [0.22-1.18],0.1183812642904926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,14417,95,0.90 [0.61-1.32],0.5724866898837255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,16186,102,1.09 [0.81-1.46],0.586387554284057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,14096,95,1.13 [0.79-1.60],0.5006398559076799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,16186,102,1.02 [0.77-1.33],0.9135837973572176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,13971,93,0.89 [0.62-1.29],0.5525027107272846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,13971,93,0.92 [0.59-1.43],0.7185128545873586
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,16186,102,1.05 [0.63-1.76],0.8380361714922054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,16536,110,0.90 [0.64-1.25],0.5292950864425467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,14096,95,1.20 [0.95-1.52],0.1343359956324695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,14479,98,1.09 [0.73-1.64],0.6691220560783526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,14003,91,0.88 [0.66-1.18],0.384128559374984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,14181,95,1.07 [0.84-1.35],0.5932796457180317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,14404,96,1.28 [0.94-1.75],0.1128262133286056
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",13971,93,0.87 [0.59-1.28],0.4857182900317313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,16186,102,1.21 [0.91-1.61],0.1919350798759173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,14046,96,0.78 [0.42-1.44],0.4307124086980732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,16723,107,1.24 [0.81-1.90],0.3300874335791856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,16271,105,1.26 [0.78-2.03],0.3466794359064673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,14209,95,1.25 [1.05-1.50],0.0144046450263728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,14404,96,1.00 [0.79-1.27],0.9725065436207492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,14362,98,0.96 [0.57-1.64],0.8885283938988736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,16222,104,0.96 [0.77-1.18],0.687658662781545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,14417,95,1.02 [0.77-1.35],0.9102521431370754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,14417,95,1.05 [0.72-1.53],0.8052720196011942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,16497,109,0.48 [0.21-1.08],0.0753251865978066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,16186,102,0.93 [0.72-1.20],0.5881120471656003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,13971,93,1.26 [0.92-1.71],0.1449668863016125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,14404,96,1.28 [0.99-1.66],0.0572544506938969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,16723,107,1.86 [1.15-3.01],0.0110337344416606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,16643,113,1.55 [1.03-2.33],0.0374877216646987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,16606,104,1.56 [1.13-2.15],0.0072829234508654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,14046,96,0.60 [0.35-1.04],0.0682102641654425
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16626,113,0.99 [0.77-1.27],0.9224044804602762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14417,95,1.03 [0.81-1.32],0.8112943977655622
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,14023,89,1.17 [0.88-1.55],0.2777249950732513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,14437,97,1.04 [0.84-1.29],0.7216856739945718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,16562,112,0.99 [0.81-1.19],0.8828642834588446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,14023,89,0.92 [0.59-1.42],0.7035769353875768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,16637,112,1.00 [0.83-1.20],0.9961653104077766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,14444,95,1.07 [0.76-1.49],0.7128983580198531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,14181,95,1.02 [0.86-1.21],0.8119321450742486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,16424,105,1.20 [0.93-1.56],0.1564019834538735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",14109,95,0.81 [0.43-1.52],0.5116142274140192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',14454,97,1.36 [1.03-1.80],0.030335941600251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,14003,91,1.05 [0.76-1.44],0.7699997207054073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,14181,95,1.37 [0.96-1.94],0.0815621618520359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,14404,96,1.19 [0.78-1.80],0.4171071095174737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,14417,95,1.21 [0.98-1.48],0.0719843154819508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,14109,95,1.54 [0.84-2.81],0.1593950883259672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,16562,112,1.16 [0.91-1.48],0.2320889588629877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],16287,109,1.16 [0.82-1.65],0.3962092516989856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",16588,110,1.69 [1.17-2.44],0.0052561200330051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,14485,98,1.00 [0.73-1.38],0.9821329084991992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,14444,95,1.48 [1.10-1.99],0.0091072118091058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,16222,104,1.44 [0.90-2.31],0.1332155743793169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,16641,107,1.21 [0.93-1.56],0.1520322875087771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,16534,110,1.70 [1.10-2.63],0.01685085191254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,16534,110,0.78 [0.51-1.21],0.271252193311951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,14096,95,0.87 [0.56-1.35],0.5310783991780254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,14415,95,1.13 [0.51-2.52],0.7673678255823901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,14096,95,1.20 [0.58-2.51],0.624971714755632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,14444,95,1.20 [0.66-2.18],0.5604113428869528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,14444,95,1.17 [0.87-1.58],0.2956619254861909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,16637,112,0.94 [0.75-1.19],0.6349967579461047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,16610,111,0.67 [0.36-1.26],0.2117254658070197
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,14181,95,1.23 [0.95-1.59],0.1133236560683319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,14466,98,1.05 [0.58-1.88],0.8816182005162143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,16588,110,1.76 [1.26-2.46],0.0009174395802593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,14181,95,0.79 [0.45-1.37],0.399200718903409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,16536,110,1.30 [1.03-1.64],0.02725435212069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,16588,110,0.81 [0.49-1.33],0.4050746407928051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,16723,107,1.02 [0.74-1.42],0.8910361020339875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,14003,91,0.67 [0.35-1.29],0.2315726343393488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,16545,110,5.77 [3.65-9.14],6.922084451922607e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,16643,113,1.31 [0.86-2.00],0.2051605506791014
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,14404,96,1.08 [0.94-1.24],0.2573533310703692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,16424,105,0.54 [0.28-1.05],0.0703511368297081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,16592,113,2.64 [1.69-4.13],2.072330661399164e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,16493,110,2.86 [1.85-4.44],2.5560874105280944e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,16757,112,1.90 [1.34-2.69],0.0003318534608164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",14046,96,0.84 [0.51-1.39],0.5094174631020716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,13971,93,1.12 [0.84-1.50],0.4488003940369149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,14209,95,1.13 [0.92-1.39],0.2523990782614215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,14454,97,0.91 [0.68-1.21],0.5133477797161108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,16279,105,1.04 [0.86-1.26],0.683868763828257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",14023,89,1.32 [0.77-2.27],0.3199502842039068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,14454,97,1.19 [0.77-1.83],0.4339543487493414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,16608,112,0.97 [0.84-1.12],0.6875043416351303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,16497,109,1.27 [0.97-1.66],0.0883497350409369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,16536,110,1.07 [0.88-1.31],0.4936307850217918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,14466,98,3.62 [2.30-5.71],3.0578289722216e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,16186,102,1.08 [0.82-1.43],0.5662907609096234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",14046,96,0.73 [0.39-1.38],0.3344572540272816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16534,110,0.90 [0.78-1.04],0.1541434369401553
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16666,111,1.62 [1.09-2.40],0.0160510848722931
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,13971,93,0.58 [0.27-1.25],0.1649989028536872
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,14404,96,1.25 [0.88-1.80],0.2164734990259782
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,14181,95,1.05 [0.74-1.49],0.7804867147835044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16497,109,1.23 [0.85-1.77],0.2665620535925139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16779,112,1.80 [1.17-2.77],0.0079132338223486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",14046,96,0.77 [0.46-1.28],0.3116100577401023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,14479,98,1.77 [0.89-3.55],0.1057606691916924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,14417,95,1.35 [0.85-2.14],0.2056340914224968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,16394,104,1.00 [0.76-1.32],0.9839514234327188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,14046,96,1.15 [0.89-1.49],0.2774010904535535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,16497,109,1.02 [0.90-1.16],0.75051492438225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,13971,93,1.05 [0.78-1.41],0.7660782808573168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,16696,107,1.85 [1.32-2.58],0.0003473240109723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,16570,109,0.97 [0.48-1.96],0.9225510707657448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,14023,89,0.81 [0.58-1.13],0.2162911592464572
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,16566,110,1.06 [0.82-1.38],0.6399697794384183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,16271,105,1.09 [0.86-1.38],0.4883079271744457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,16186,102,0.95 [0.71-1.27],0.712453756817775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,16562,112,1.05 [0.87-1.28],0.5951471318278566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",13971,93,1.11 [0.91-1.36],0.2990736146653076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,16222,104,1.03 [0.77-1.40],0.8238488860804876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,14096,95,1.33 [0.91-1.94],0.1375645546012786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,14454,97,1.13 [0.71-1.79],0.5977190684719786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,16497,109,1.09 [0.83-1.44],0.5486690187609884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,14046,96,1.16 [0.74-1.80],0.5195839414630876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,16222,104,0.80 [0.58-1.09],0.159524846796043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,14046,96,0.72 [0.48-1.08],0.1115752868077888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,16536,110,0.91 [0.63-1.31],0.5959617241673036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,14444,95,1.20 [0.93-1.55],0.1695073884855968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,16222,104,0.90 [0.59-1.38],0.639427733546194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,14404,96,1.15 [0.71-1.86],0.5619988392877595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,16222,104,1.06 [0.85-1.32],0.6127819568505837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,16696,107,1.00 [0.88-1.14],0.9814376692928458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,16536,110,1.58 [1.28-1.95],2.1283092128247582e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,14046,96,1.09 [0.83-1.42],0.5541485539917282
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16696,107,1.29 [0.91-1.81],0.1494249997529386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",14444,95,1.57 [1.22-2.03],0.0004884114110876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,16271,105,0.78 [0.55-1.10],0.1595069809520026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,16588,110,1.77 [1.06-2.97],0.0292326982691408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,14417,95,1.00 [0.63-1.61],0.9851211049135494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,14103,94,1.21 [0.68-2.14],0.5205632589902016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,14096,95,1.10 [0.81-1.48],0.5522328754031459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,14404,96,1.43 [0.91-2.24],0.1181023753025528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,14181,95,1.19 [0.86-1.66],0.2967417105030587
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,14023,89,1.04 [0.75-1.46],0.8020486468512975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,14454,97,0.81 [0.47-1.39],0.444467458688035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,14466,98,1.12 [0.87-1.45],0.3705975664412394
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,14209,95,1.06 [0.88-1.28],0.5314726004640026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,16497,109,1.03 [0.89-1.19],0.7243320384767684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,14702,92,2.64 [1.81-3.85],4.95146799953774e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,14417,95,0.78 [0.47-1.29],0.3302812233090824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,16497,109,1.23 [0.79-1.91],0.36290972437883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,13971,93,0.90 [0.64-1.27],0.5574939402598654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,14418,98,1.35 [0.88-2.06],0.1659446186848577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,16279,105,0.92 [0.71-1.19],0.5218869717883521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,14209,95,0.97 [0.69-1.38],0.8833075047174669
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,16186,102,1.00 [0.80-1.26],0.980044847163515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",14096,95,1.00 [0.77-1.29],0.9992031694100691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",14417,95,1.11 [0.67-1.84],0.6826280599368737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,14454,97,1.32 [0.99-1.77],0.0574964775037041
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,16186,102,1.07 [0.73-1.56],0.7313972878084438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,16497,109,0.96 [0.79-1.16],0.6867321749203137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,16536,110,0.91 [0.73-1.14],0.4162371741973888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,14181,95,1.13 [0.89-1.43],0.3034711411781225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,16424,105,1.04 [0.87-1.24],0.6441462795538171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,16424,105,1.03 [0.83-1.28],0.7999352885366765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,16222,104,0.99 [0.80-1.21],0.8908608100366043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,14096,95,1.12 [0.78-1.60],0.5317738477139606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,16407,105,1.13 [0.95-1.34],0.1676625724907185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,16271,105,0.90 [0.71-1.15],0.4017906957498501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,14181,97,1.12 [0.65-1.92],0.6813824837953262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,16757,112,1.55 [0.95-2.52],0.0819313492771331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,14466,98,1.87 [1.20-2.92],0.0059867320178514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,14209,95,0.91 [0.62-1.34],0.6249078776965138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,14466,98,1.91 [1.01-3.60],0.0470308900610454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,16186,102,0.99 [0.88-1.12],0.8927224103803695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",14096,95,1.29 [0.84-1.98],0.2395619333423659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,14417,95,1.22 [0.97-1.54],0.0897725505473701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,16186,102,0.87 [0.70-1.09],0.2298699193180308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,14003,91,0.87 [0.53-1.43],0.578973255368976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,16637,112,2.42 [1.16-5.07],0.0185958485800637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,14046,96,0.68 [0.33-1.40],0.2991409902707006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,14173,95,1.03 [0.85-1.24],0.758523171153259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,14096,95,0.70 [0.48-1.02],0.0625856531099689
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,14209,95,0.67 [0.36-1.26],0.2133173638822729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,14494,98,0.67 [0.28-1.63],0.3769920309247907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,14023,89,0.89 [0.62-1.28],0.5349996089998632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,16511,108,1.16 [0.96-1.41],0.1311438832626878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,16618,113,1.33 [1.01-1.75],0.0395464511241705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,16578,111,1.40 [0.99-1.98],0.0586793755835351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,16565,108,1.13 [0.66-1.95],0.6592497608523684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,16593,111,1.49 [1.15-1.94],0.0024183486985349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,16660,111,1.02 [0.66-1.58],0.93114351829895
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,14417,95,0.98 [0.82-1.17],0.8284962740245498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,16536,110,1.39 [1.00-1.95],0.0526800823449824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,16714,109,1.86 [1.29-2.67],0.0008384612502037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,14417,95,0.87 [0.59-1.27],0.4647436213185975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,16508,108,3.49 [2.01-6.07],9.121053479957546e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,14046,96,0.85 [0.33-2.16],0.7319840337803867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,16637,112,1.90 [1.25-2.90],0.0027707168062783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,16779,112,0.86 [0.51-1.45],0.5685549041155562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,16543,112,1.20 [0.97-1.49],0.0996479755958216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,14485,98,1.76 [0.89-3.48],0.1054604738928726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,13949,93,1.03 [0.83-1.29],0.7706925322227202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,16562,112,1.32 [0.76-2.30],0.3259963140769171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,16588,110,3.42 [2.64-4.44],1.8384010731199042e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,16604,109,1.38 [0.96-2.00],0.0846497494991189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,16473,110,1.39 [0.82-2.34],0.2194625257487883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,16271,105,0.77 [0.49-1.21],0.258489572571271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,14003,91,1.06 [0.89-1.26],0.534503472521694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,13932,94,0.92 [0.50-1.68],0.7822657317340562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,14392,95,1.02 [0.81-1.28],0.851328986710614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,16696,107,2.20 [1.27-3.82],0.0051368331840733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,16087,100,1.03 [0.89-1.19],0.6863368140384029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,16779,112,1.44 [0.90-2.31],0.1252134336755871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16156,101,1.05 [0.71-1.54],0.809389728863452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14209,95,1.48 [1.04-2.10],0.0291958597134366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16666,111,2.00 [1.39-2.86],0.0001601005520655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14466,98,1.43 [0.91-2.25],0.1191061141320119
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,14454,97,1.12 [0.89-1.40],0.3421479115437809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,16434,110,4.22 [2.99-5.95],2.8751083758093714e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,14466,98,0.82 [0.36-1.86],0.6369897719232473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,16643,113,0.99 [0.87-1.12],0.8255430992949467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,16588,110,1.24 [0.83-1.85],0.2935274635009401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,16510,110,2.42 [1.15-5.12],0.0205062807567608
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,16637,112,1.00 [0.82-1.23],0.9820331617556414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,14023,89,0.79 [0.47-1.35],0.3891550092510084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",14209,95,0.96 [0.61-1.53],0.8791340566791265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,14046,96,2.35 [1.26-4.40],0.0073609464969528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,14209,95,2.29 [1.00-5.26],0.0508530928150189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,16739,109,1.10 [0.83-1.46],0.5044841249700105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,14046,96,0.77 [0.38-1.56],0.4673383338104081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,14096,95,1.14 [0.82-1.61],0.4357159439789454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,14209,95,0.78 [0.52-1.17],0.2376115563886358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,14003,91,0.56 [0.28-1.12],0.10128358202111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,14003,91,0.66 [0.42-1.06],0.084099477539224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,14404,96,1.04 [0.86-1.26],0.6735313644249856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,14417,95,1.02 [0.78-1.35],0.8727181182090892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,14109,95,1.13 [0.83-1.53],0.435570072437852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,14444,95,1.33 [0.96-1.85],0.0834543262569239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,13971,93,0.88 [0.52-1.47],0.6157717627269668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,14023,89,0.95 [0.71-1.26],0.698999109779783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,14429,97,1.32 [0.84-2.09],0.2262004506510677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,16497,109,1.11 [0.92-1.34],0.2689372989653265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,16351,104,0.86 [0.55-1.35],0.5133121733429061
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,16588,110,1.21 [0.96-1.52],0.1101439327430794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,16666,111,0.86 [0.60-1.22],0.385783375234028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,16246,105,1.16 [0.76-1.76],0.5022069280659365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,14404,96,1.33 [0.92-1.90],0.1244807357511692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,16279,105,0.94 [0.58-1.52],0.8112145076917665
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,14181,95,1.13 [0.83-1.55],0.4338813791439749
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16424,105,1.80 [1.16-2.78],0.0081697590780944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16424,105,1.40 [1.14-1.72],0.0013744030676924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16621,111,1.21 [0.85-1.72],0.2932295929233716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16739,109,2.12 [1.47-3.06],5.615790455481407e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16564,113,4.03 [2.46-6.59],2.8690280740996483e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16637,112,1.87 [1.22-2.88],0.0042442559807189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16592,113,1.97 [1.38-2.82],0.0001809971452905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16279,105,1.11 [0.72-1.71],0.6313228984842489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16592,113,2.14 [1.32-3.46],0.001969516067456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14181,95,1.68 [1.05-2.68],0.0310053867102832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16723,107,1.59 [0.99-2.55],0.0575120941991288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16588,110,2.51 [1.60-3.95],6.803659418798645e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16588,110,1.61 [1.24-2.10],0.0004392568894334
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16696,107,2.90 [1.66-5.06],0.0001780773386651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16714,109,1.57 [1.04-2.37],0.0335778405698812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16424,105,1.54 [1.20-1.99],0.0007692685013907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16696,107,1.37 [0.97-1.95],0.0769507844137944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16424,105,1.61 [1.12-2.32],0.0103507523705135
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,16739,109,0.55 [0.28-1.05],0.069278551151026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,16536,110,0.61 [0.46-0.81],0.0005680321029768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,16739,109,0.70 [0.38-1.27],0.2397937000279399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,16643,113,1.76 [0.96-3.23],0.0694277065331381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16759,112,1.95 [1.18-3.20],0.0086586693659373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,16424,105,1.16 [0.86-1.56],0.3400043010335359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14479,98,2.32 [1.51-3.58],0.0001398684526599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,14454,97,1.09 [0.87-1.35],0.4587820584220239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,14479,98,0.97 [0.62-1.50],0.8841558837816149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",16271,105,0.82 [0.69-0.97],0.0197350215534319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,14209,95,0.91 [0.51-1.62],0.7525764354663621
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,16424,105,0.84 [0.56-1.26],0.3995046435663383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,16588,110,0.90 [0.46-1.73],0.743225920280077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,14466,98,1.24 [0.98-1.57],0.0789583779239936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,14404,96,0.97 [0.82-1.15],0.7096401812364938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",13971,93,0.86 [0.55-1.35],0.5198969415402468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,14046,96,1.14 [0.90-1.46],0.2836584215341382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,14109,95,1.19 [0.85-1.67],0.3102825098571194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,16222,104,1.08 [0.72-1.62],0.72689555145741
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,14046,96,1.15 [0.92-1.44],0.2045697811778031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,13871,93,1.37 [0.95-1.99],0.0927224863427703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,16271,105,0.51 [0.24-1.09],0.0831859741491032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,14096,95,1.19 [0.66-2.12],0.561388021702004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,14096,95,1.07 [0.69-1.67],0.7673501024413915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,14181,95,1.08 [0.89-1.30],0.445009952975074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,14466,98,0.80 [0.39-1.61],0.5271982716489705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,14003,91,0.88 [0.55-1.42],0.6037851850771333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,16222,104,1.11 [0.88-1.40],0.3815541153757267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,16456,113,1.66 [1.23-2.23],0.0008571452846898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,14209,95,1.00 [0.78-1.28],0.9925818711033416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,16186,102,1.21 [0.82-1.79],0.3309525910618787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,14003,91,1.22 [0.88-1.70],0.2399061325226233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,13971,93,1.04 [0.78-1.40],0.7662283787333086
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,16715,108,1.03 [0.75-1.43],0.8435016745574861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,14444,95,0.95 [0.56-1.62],0.8434693652073206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,14046,96,1.03 [0.49-2.16],0.9348259461763726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,16279,105,0.84 [0.62-1.16],0.2879473310550034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,16536,110,1.02 [0.80-1.30],0.8927697018083818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",14046,96,0.93 [0.54-1.60],0.7970494535642454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,14003,91,0.97 [0.64-1.49],0.9050563055610304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,14209,95,1.03 [0.83-1.29],0.7739740719132056
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,14479,98,1.19 [0.91-1.55],0.2002903630040721
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,16564,113,1.32 [0.98-1.79],0.0723847648656442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,14485,98,1.02 [0.70-1.47],0.9354120733587152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,16588,110,1.20 [0.73-1.98],0.4648505865774064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,16723,107,1.05 [0.79-1.39],0.7259533300281449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,16536,110,0.99 [0.79-1.23],0.899959949070033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,14185,95,1.13 [0.85-1.52],0.4002146525167138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,14404,96,0.99 [0.82-1.18],0.8973816285850079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,13971,93,1.23 [0.93-1.62],0.1427647054678855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,14096,95,1.09 [0.83-1.43],0.5164343003296649
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,16536,110,1.04 [0.85-1.27],0.6835591432085286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,14417,95,0.92 [0.73-1.15],0.4734634513583584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,14003,91,0.72 [0.45-1.17],0.184201790769966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,14046,96,0.73 [0.50-1.06],0.0975281140820902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,14444,95,1.12 [0.84-1.50],0.4285521781738018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,16562,112,0.98 [0.79-1.21],0.8689090023380924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,16271,105,0.85 [0.61-1.17],0.3210645010301317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,14003,91,0.91 [0.54-1.53],0.7278517013099117
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,16271,105,0.98 [0.77-1.24],0.8501348711584513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,14003,91,1.12 [0.78-1.62],0.5397784775468245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,14023,89,0.98 [0.78-1.22],0.8379866474016138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,14404,96,1.45 [1.21-1.75],8.628626581628782e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,14046,96,1.25 [0.78-1.99],0.35657580044338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,16150,102,1.02 [0.80-1.29],0.8840991165964629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,14096,95,1.36 [0.93-1.97],0.1091084504205103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,14003,91,1.05 [0.78-1.42],0.7468304742393485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,14338,98,0.36 [0.17-0.74],0.00588205022383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,14023,89,0.67 [0.32-1.42],0.3003181696530685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,14479,98,1.08 [0.86-1.36],0.5011499952630611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,14209,95,1.09 [0.87-1.37],0.4609716031994781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,16424,105,1.05 [0.86-1.29],0.6077534942627112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,14242,96,1.12 [0.74-1.71],0.5963244574825994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,16637,112,2.33 [1.35-4.04],0.0024992500645746
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,16696,107,1.05 [0.82-1.36],0.693495691335986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,14454,97,1.18 [0.82-1.69],0.3657198961881449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,13997,89,1.10 [0.91-1.32],0.3346428535297033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16588,110,1.40 [0.98-1.99],0.0639055301116579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,16453,112,1.34 [1.04-1.73],0.0255943107101595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,16562,112,1.66 [0.92-3.01],0.0938850169684264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",14046,96,1.01 [0.74-1.37],0.968653782213628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,16497,109,1.18 [0.72-1.92],0.5160708116365257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,14417,95,1.08 [0.56-2.10],0.8213348417441164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,14466,98,1.31 [0.96-1.78],0.09367401540688
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,14046,96,0.82 [0.56-1.21],0.3230084022872929
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,14003,91,0.91 [0.62-1.35],0.6436893617244188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,14181,95,1.12 [0.84-1.49],0.4277075344131688
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,14404,96,1.04 [0.90-1.20],0.5737323354777754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,14003,91,1.03 [0.84-1.26],0.7900104127740092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,14003,91,0.76 [0.39-1.47],0.4098776148425244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,16424,105,2.13 [1.44-3.16],0.0001637878760035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,16737,112,0.71 [0.53-0.94],0.016025391034708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,14046,96,1.00 [0.46-2.16],0.9942887603899796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,13971,93,1.17 [0.84-1.64],0.3569164544495817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,14417,95,1.19 [0.71-2.00],0.5137305582577931
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,14466,98,1.25 [1.03-1.53],0.0260449268472928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,14023,89,1.03 [0.69-1.54],0.9017955481078472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,14179,95,1.13 [0.83-1.54],0.427164996870445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,14181,95,0.99 [0.74-1.33],0.956080825450412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,14096,95,0.75 [0.54-1.04],0.0865868106753661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,16497,109,1.01 [0.84-1.22],0.8915827992601628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,14417,95,1.04 [0.79-1.38],0.7557352125246686
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,14454,97,1.52 [1.02-2.27],0.0388662112266023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,14003,91,0.96 [0.75-1.23],0.7452547590063077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,16271,105,1.06 [0.88-1.28],0.5152397134760462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,16222,104,1.35 [1.02-1.78],0.0373182890704296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,16271,105,1.33 [1.05-1.69],0.0177614365243521
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,14046,96,1.08 [0.87-1.36],0.4848677420855871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,16536,110,0.97 [0.79-1.19],0.7733395040040569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,16329,110,0.91 [0.49-1.71],0.7723421504886123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,14485,98,1.18 [0.90-1.53],0.2233203707676556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16497,109,0.46 [0.19-1.12],0.0876727966340059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,14023,89,1.05 [0.85-1.29],0.6724727676592032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,16634,109,3.51 [2.14-5.77],6.921858562928611e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,16696,107,0.81 [0.46-1.45],0.4830518419775784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,13971,93,1.27 [1.07-1.50],0.0060072213240992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,16693,108,1.12 [0.84-1.50],0.4424567745443321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,14046,96,2.37 [1.24-4.55],0.0091144908959011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,16637,112,1.00 [0.74-1.34],0.9947800758815144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,16712,109,1.45 [0.92-2.28],0.1058293500741836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,14444,95,0.98 [0.52-1.86],0.9595600040231592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,16271,105,0.99 [0.85-1.14],0.8492303862580821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,14109,95,0.75 [0.31-1.81],0.5198380790198012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,14466,98,0.88 [0.53-1.47],0.6267830754884469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,16497,109,1.00 [0.78-1.27],0.9896845103475004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,14485,98,1.06 [0.81-1.38],0.6862915034518932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,16497,109,1.12 [0.77-1.64],0.5560638986942451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,14209,95,1.02 [0.76-1.38],0.879562271038064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,16497,109,1.00 [0.80-1.23],0.9729409641652996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,14417,95,1.00 [0.81-1.24],0.9920744446302636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,16497,109,1.03 [0.83-1.28],0.7876259090947008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,14417,95,1.19 [0.69-2.06],0.5366782438970532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,14003,91,0.77 [0.41-1.47],0.431665573973085
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,14417,95,1.39 [1.08-1.79],0.0116808927384775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,16570,109,1.60 [1.09-2.34],0.0160099573046595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16533,112,1.21 [0.94-1.56],0.1463276167137638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,14454,97,1.40 [0.88-2.22],0.1617925361638937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,16186,102,1.05 [0.75-1.48],0.7572066294983963
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,14209,95,1.31 [0.90-1.89],0.1597233018598349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,16271,105,0.89 [0.65-1.22],0.4746364443640571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16696,107,1.11 [0.87-1.40],0.4070375413626956
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,16222,104,1.65 [0.96-2.84],0.0712611087732698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14181,95,1.17 [0.84-1.64],0.3539399555618301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,16693,107,1.19 [0.79-1.79],0.4085963214871638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,13971,93,1.19 [0.98-1.45],0.086644139234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,16365,103,1.08 [0.70-1.66],0.7315062182253238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,14444,95,0.86 [0.53-1.39],0.5355032334600125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,16779,112,1.09 [0.87-1.37],0.448890527036335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",16588,110,1.19 [0.76-1.86],0.4507325554673175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,16279,105,0.96 [0.73-1.26],0.7620877969824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,16271,105,1.03 [0.86-1.25],0.7218351648217639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,16186,102,0.98 [0.79-1.20],0.8190937539306214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,14454,97,1.15 [0.89-1.47],0.2810655973535444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,14046,96,0.80 [0.55-1.16],0.2342086093427431
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,14417,95,1.36 [0.85-2.19],0.1972260118116504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,14111,94,1.09 [0.79-1.52],0.5989618410655259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,16702,107,1.25 [0.96-1.61],0.0939019731831542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,15760,104,1.62 [1.11-2.37],0.0122825811856293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",16371,104,0.58 [0.39-0.87],0.0091126973534533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16592,113,0.98 [0.60-1.60],0.9287062511668108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,16723,107,0.92 [0.56-1.52],0.7387569950944887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,16279,105,1.62 [0.98-2.67],0.0604770281712088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,16424,105,0.91 [0.66-1.27],0.5942957415047194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,16723,107,1.33 [1.03-1.73],0.0303043137473861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,16705,112,0.84 [0.52-1.36],0.4891901421851086
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,14046,96,1.08 [0.77-1.53],0.6585624024433299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,16637,112,1.15 [0.97-1.37],0.1024807694433252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,16186,102,0.78 [0.47-1.28],0.3226232319407304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,14454,97,2.24 [1.32-3.78],0.0026226579137026
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",14404,96,1.06 [0.93-1.22],0.390820274905023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,16497,109,0.99 [0.86-1.15],0.9345828271970124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,14417,95,1.17 [0.65-2.12],0.594509872613904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,14003,91,0.92 [0.67-1.27],0.619855185588698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,16279,105,1.02 [0.83-1.25],0.8531464307010447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,14181,95,1.09 [0.84-1.43],0.5144351592053742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,14046,96,0.70 [0.33-1.45],0.333677913454769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,14046,96,1.38 [0.90-2.12],0.134212954121158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,16222,104,0.92 [0.71-1.18],0.4954582728397724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,16271,105,1.51 [1.13-2.01],0.0055526586501558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,14003,91,0.96 [0.68-1.35],0.8194619590301735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,14404,96,1.01 [0.81-1.25],0.959490056284344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,14454,97,1.71 [1.20-2.44],0.0027562183925081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,14046,96,1.26 [0.83-1.93],0.2739707434153139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,14209,95,1.23 [0.95-1.59],0.1211163372602281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,14417,95,1.06 [0.83-1.36],0.6162048226092645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,14404,96,1.19 [0.91-1.56],0.2139549423210135
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,14417,95,1.13 [0.80-1.59],0.5004156087606286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,14109,95,1.03 [0.96-1.12],0.3809137541879512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,13971,93,0.64 [0.30-1.36],0.2457165886476772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,14023,89,0.92 [0.73-1.16],0.4740231199610233
